Processing 00000000.tx.1: Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias  Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias Giovanni Stevanin1, Yvon Trottier2, Graldine Cancel1, Alexandra Drr1, Gilles David1, Olivier Didierjean1, Katrin Brk3, Georges Imbert2, Frederic Saudou2, Myriem Abada-Bendib1,4, Isabelle Gourfinkel-An1, Ali Benomar5, Nacer Abbas1, Thomas Klockgether3, Djamel Grid6,+, Yves Agid1, Jean-Louis Mandel2 and Alexis Brice1,* 1INSERM U289 and Fdration de Neurologie, Hpital de la Salptrire, Paris, France, 2Institut de Gntique et de Biologie Molculaire et Cellulaire (IGBMC), Illkirch, CU de Strasbourg, France, 3Department of Neurology, University of Tbingen, Tbingen, Germany, 4Service de Neurologie, Hpital de Ben-Aknoun, CHU Alger-ouert, Algiers, Algeria and 5Service de Neurologie, Hpital des Spcialits, Rabat, Morocco, 6Service de Neurologie, CHU Mustapha, Algiers, Algeria Received July 30, 1996; 

Phrase: "Screening for proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0220908:Screening [Health Care Activity]
   790   C0220909:screening [Functional Concept]
   790   C1698960:screening [Intellectual Product]
   790   C1710031:Screening [Diagnostic Procedure]
   790   C1710477:SCREENING [Research Activity]

Phrase: "with polyglutamine expansions"

Phrase: "in autosomal dominant cerebellar ataxias"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0007758:Cerebellar Ataxias [Sign or Symptom]
   861   C0443147:Autosomal dominant [Intellectual Product]
   812   C0004134:Ataxias [Sign or Symptom]
   812   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   812   C0596142:autosomal [Cell Component]
   812   C1527180:Dominant [Functional Concept]
   812   C1707522:Cerebellar [Tissue]
   729 E C0234366:Ataxic [Sign or Symptom]

Phrase: "Screening for proteins"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0220908:Screening [Health Care Activity]
   790   C0220909:screening [Functional Concept]
   790   C1698960:screening [Intellectual Product]
   790   C1710031:Screening [Diagnostic Procedure]
   790   C1710477:SCREENING [Research Activity]
   756 E C1305399:screen [Functional Concept]
   756 E C1705053:Screen [Medical Device]

Phrase: "with polyglutamine expansions"

Phrase: "in autosomal dominant cerebellar ataxias Giovanni Stevanin1,"

Phrase: "Yvon Trottier2,"

Phrase: "Graldine Cancel1,"

Phrase: "Alexandra Drr1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1842306:DRR1 [Gene or Genome]

Phrase: "Gilles David1,"

Phrase: "Olivier Didierjean1,"

Phrase: "Katrin Brk3,"

Phrase: "Georges Imbert2,"

Phrase: "Frederic Saudou2,"

Phrase: "Myriem Abada-Bendib1,"

Phrase: "4,"

Phrase: "Isabelle Gourfinkel-An1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0344542:AN1 [Congenital Abnormality]

Phrase: "Ali Benomar5,"

Phrase: "Nacer Abbas1,"

Phrase: "Thomas Klockgether3,"

Phrase: "Djamel Grid6,"

Phrase: "+,"

Phrase: "Yves Agid1,"

Phrase: "Jean-Louis Mandel2"

Phrase: "and"

Phrase: "Alexis Brice1,"

Phrase: "* 1INSERM U289"

Phrase: "and"

Phrase: "Fdration de Neurologie,"

Phrase: "Hpital de la Salptrire,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "2Institut de Gntique et de Biologie Molculaire et Cellulaire"

Phrase: "(IGBMC"

Phrase: ")"

Phrase: ","

Phrase: "Illkirch,"

Phrase: "CU de Strasbourg,"

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "3Department of Neurology,"

Phrase: "University of Tbingen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "Tbingen,"

Phrase: "Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "4Service de Neurologie,"

Phrase: "Hpital de Ben-Aknoun,"

Phrase: "CHU Alger-ouert,"

Phrase: "Algiers,"

Phrase: "Algeria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002037:Algeria [Geographic Area]

Phrase: "and"

Phrase: "5Service de Neurologie,"

Phrase: "Hpital des Spcialits,"

Phrase: "Rabat,"

Phrase: "Morocco,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026544:Morocco [Geographic Area]

Phrase: "6Service de Neurologie,"

Phrase: "CHU Mustapha,"

Phrase: "Algiers,"

Phrase: "Algeria Received July 30,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0002037:Algeria [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "1996"

Phrase: ";"
Processing 00000000.tx.2: Revised and Accepted September 16, 1996 Expansion of trinucleotide CAG repeats coding for polyglutamine has been implicated in five neurodegenerative disorders, including spinocerebellar ataxia (SCA) 1 and SCA3 or Machado-Joseph disease (SCA3/MJD), two forms of type I autosomal dominant cerebellar ataxias (ADCA). 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted September 16,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1996 Expansion of trinucleotide CAG repeats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   803   C0524894:Trinucleotide Repeat Expansion [Cell or Molecular Dysfunction]

Phrase: "coding for polyglutamine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009219:Coding [Occupational Activity]
   790   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   756 E C0805701:Code [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in five neurodegenerative disorders,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   806   C1522560:Neurodegenerative Disorders [Functional Concept]
   760   C0012634:Disorders [Disease or Syndrome]
   760   C0205451:Five [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "spinocerebellar ataxia (SCA) 1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0752120:Spinocerebellar Ataxia-1 [Disease or Syndrome]
   901   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   827   C0004134:Ataxia [Sign or Symptom]
   755 E C0234366:Ataxic [Sign or Symptom]

Phrase: "and"

Phrase: "SCA3 or Machado-Joseph disease (SCA3/MJD),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0024408:SCA3 [Disease or Syndrome]
           Machado-Joseph Disease

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "forms of type I autosomal dominant cerebellar ataxias"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   793   C0441735:Dominant type I [Intellectual Product]
   789   C3463805:Type of Form [Intellectual Product]
           form type
   770   C0007758:Cerebellar Ataxias [Sign or Symptom]
   770   C0441729:Type I [Classification]
   770   C0443147:Autosomal dominant [Intellectual Product]
   744   C0004134:Ataxias [Sign or Symptom]
   744   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   744   C0021966:I- [Inorganic Chemical]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0332307:Type [Qualitative Concept]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C0596142:autosomal [Cell Component]
   744   C1522492:Form [Functional Concept]
   744   C1527180:Dominant [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1707522:Cerebellar [Tissue]

Phrase: "(ADCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
  1000   C1418447:ADCA [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.3: Using the 1C2 antibody which specifically recognizes large polyglutamine tracts, particularly those that are expanded, we recently reported the detection of proteins with pathological glutamine expansions in lymphoblasts from another form of ADCA type I, SCA2, as well as from patients presenting with the distinct phenotype of ADCA type II. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 1C2 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which specifically"

Phrase: "recognizes"

Phrase: "large polyglutamine tracts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:tracts [Body Part, Organ, or Organ Component]

Phrase: "particularly"

Phrase: "those that"

Phrase: "are"

Phrase: "expanded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:expanded [Spatial Concept]

Phrase: ","

Phrase: "we recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "the detection of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "with pathological glutamine expansions"

Phrase: "in lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0229613:Lymphoblasts [Cell]
  1000   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "from another form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "of ADCA type I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "SCA2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: "as well as from patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]

Phrase: "presenting with the distinct phenotype of ADCA type II."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   784   C0752125:ADCA, TYPE II [Disease or Syndrome]
   764   C0441730:Type II [Classification]
   742   C0031437:Phenotype [Organism Attribute]
   742   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   742   C0332307:Type [Qualitative Concept]
   742   C0449450:Presenting [Idea or Concept]
   742   C1285572:Phenotype [Laboratory Procedure]
   742   C1418447:ADCA [Gene or Genome]
   742   C1547052:*Type [Quantitative Concept]
   708 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.4: We now have screened a large series of patients with ADCA or isolated cases with cerebellar ataxia, for the presence of proteins with polyglutamine expansions. 

Phrase: "We now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "have"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "a large series of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "with ADCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
  1000   C1418447:ADCA [Gene or Genome]

Phrase: "or"

Phrase: "isolated cases with cerebellar ataxia,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C1853237:Isolated cases [Finding]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "for the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with polyglutamine expansions."
Processing 00000000.tx.5: A 150 kDa SCA2 protein was detected in 16 out of 40 families with ADCA type I. 

Phrase: "A 150 kDa SCA2 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0531288:SCA2 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected in 16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "out of 40 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "with ADCA type I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.6: This corresponds to 24% of all ADCA type I families, which is much more frequent than SCA1 in this series of patients (13%). 

Phrase: "This"

Phrase: "corresponds to 24% of all ADCA type I families,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0441729:Type I [Classification]
   742   C0015576:Families [Family Group]
   742   C0021966:I- [Inorganic Chemical]
   742   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0332307:Type [Qualitative Concept]
   742   C1418447:ADCA [Gene or Genome]
   742   C1547052:*Type [Quantitative Concept]
   742   C1704727:Family [Conceptual Entity]

Phrase: "which"

Phrase: "is"

Phrase: "much more frequent than SCA1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332183:Frequent [Temporal Concept]

Phrase: "in this series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "(13%"

Phrase: ")."
Processing 00000000.tx.7: The signal intensity of the SCA2 protein was negatively correlated to age at onset, as expected for an expanded and unstable trinucleotide repeat mutation. 

Phrase: "The signal intensity of the SCA2 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0871362:signal intensity [Quantitative Concept]
   748   C0522510:Intensity [Qualitative Concept]
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "negatively"

Phrase: "correlated to age at onset,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0206132:Onset Age [Quantitative Concept]
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]
   760   C1707520:Correlated [Qualitative Concept]

Phrase: "as"

Phrase: "expected for an expanded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205229:expanded [Spatial Concept]
   770   C1517001:Expected [Idea or Concept]

Phrase: "and"

Phrase: "unstable trinucleotide repeat mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.8: The disease segregated with markers closely linked to the SCA2 locus in all identified SCA2 families. 

Phrase: "The disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "segregated with markers closely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0005516:Marker [Clinical Attribute]

Phrase: "linked to the SCA2 locus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0752121:SCA2 [Disease or Syndrome]
   760   C1334353:SCA-2 [Gene or Genome]
   760   C1705387:SCA-2 [Gene or Genome]
   760   C1708726:Locus [Gene or Genome]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "in all identified SCA2 families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.9: In addition, a specific 130 kDa protein, which segregated with the disease, was detected in lymphoblasts of patients from nine families with ADCA type II. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a specific 130 kDa protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "segregated with the disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "detected in lymphoblasts of patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0229613:Lymphoblasts [Cell]
   760   C0442726:Detected [Finding]
   760   C1167770:Lymphoblasts [Laboratory Procedure]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "from nine families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "with ADCA type II."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0441730:Type II [Classification]
Processing 00000000.tx.10: It was also visualized in the cerebral cortex of one of the patients, demonstrating its translation in the nervous system. 

Phrase: "It"

Phrase: "was"

Phrase: "also"

Phrase: "visualized in the cerebral cortex of one of the patients,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   739   C0030705:Patients [Patient or Disabled Group]
   739   C0205447:One [Quantitative Concept]
   739   C0234621:Visualized [Functional Concept]
   739   C1176472:Cortex [Body Part, Organ, or Organ Component]
   739   C2700441:Cortex [Plant]

Phrase: "demonstrating"

Phrase: "its translation in the nervous system."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040712:Translation [Intellectual Product]
   753   C0597295:translation [Molecular Function]
   753   C1519614:Translation [Genetic Function]
Processing 00000000.tx.11: Finally, no new disease-related proteins containing expanded polyglutamine tracts could be detected in lymphoblasts from the remaining patients with ADCA or isolated cases with cerebellar ataxia. 

Phrase: "Finally,"

Phrase: "no new disease-related proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "expanded polyglutamine tracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:tracts [Body Part, Organ, or Organ Component]

Phrase: "could"

Phrase: "be"

Phrase: "detected in lymphoblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0229613:Lymphoblasts [Cell]
   790   C0442726:Detected [Finding]
   790   C1167770:Lymphoblasts [Laboratory Procedure]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "from the remaining patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with ADCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
  1000   C1418447:ADCA [Gene or Genome]

Phrase: "or"

Phrase: "isolated cases with cerebellar ataxia."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C1853237:Isolated cases [Finding]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.12: INTRODUCTION The autosomal dominant cerebellar ataxias (ADCA) are a group of neurological disorders characterized clinically by progressive and unremitting cerebellar ataxia variably associated with other neurological signs. 

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "The autosomal dominant cerebellar ataxias"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0007758:Cerebellar Ataxias [Sign or Symptom]
   861   C0443147:Autosomal dominant [Intellectual Product]
   812   C0004134:Ataxias [Sign or Symptom]
   812   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   812   C0596142:autosomal [Cell Component]
   812   C1527180:Dominant [Functional Concept]
   812   C1707522:Cerebellar [Tissue]
   729 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(ADCA)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
  1000   C1418447:ADCA [Gene or Genome]

Phrase: "are"

Phrase: "a group of neurological disorders"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0441835:a group [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "clinically by progressive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205329:Progressive [Functional Concept]

Phrase: "and"

Phrase: "unremitting cerebellar ataxia variably"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0007758:Cerebellar Ataxia [Sign or Symptom]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   812   C1707522:Cerebellar [Tissue]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "associated with other neurological signs."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   781   C0521990:Associated sign [Sign or Symptom]
   760   C0205494:Neurological [Qualitative Concept]
   760   C0220912:signs [Functional Concept]
   760   C0220913:signs [Manufactured Object]
   760   C0311392:SIGNS [Finding]
   760   C2707261:Neurological [Clinical Attribute]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1547188:Sign [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.13: A classification, established on the basis of these associated signs (1 ,2 ), now includes molecular criteria (3 ,4 ). 

Phrase: "A classification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0008902:Classification [Classification]
   861   C0008903:classification [Functional Concept]
   861   C0678229:classification [Occupational Activity]

Phrase: "established on the basis of these associated signs"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   754   C0521990:Associated sign [Sign or Symptom]
   744   C0220912:signs [Functional Concept]
   744   C0220913:signs [Manufactured Object]
   744   C0311392:SIGNS [Finding]
   744   C0332281:Associated [Qualitative Concept]
   744   C0443211:Established [Qualitative Concept]
   744   C1272684:Established [Qualitative Concept]
   744   C1527178:Basis [Functional Concept]
   744   C1874451:Basis [Pharmacologic Substance]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1547188:Sign [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(1 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "molecular criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "(3 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.14: ADCA type I is the most common subtype and variably combines cerebellar ataxia and dysarthria, ophthalmoplegia, pyramidal and extrapyramidal signs, deep sensory loss, amyotrophy and dementia. 

Phrase: "ADCA type I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "the most common subtype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449560:Subtype [Classification]

Phrase: "and"

Phrase: "variably"

Phrase: "combines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336789:Combine [Manufactured Object]

Phrase: "cerebellar ataxia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007758:Cerebellar Ataxia [Sign or Symptom]
   861   C0004134:Ataxia [Sign or Symptom]
   861   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellar [Tissue]
   789 E C0234366:Ataxic [Sign or Symptom]

Phrase: "and"

Phrase: "dysarthria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013362:Dysarthria [Mental or Behavioral Dysfunction]

Phrase: "ophthalmoplegia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029089:Ophthalmoplegia [Sign or Symptom]

Phrase: "pyramidal"

Phrase: "and"

Phrase: "extrapyramidal signs,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0234133:Extrapyramidal signs [Sign or Symptom]
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "deep sensory loss,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0278134:Sensory loss [Sign or Symptom]
   827   C1517945:Loss [Quantitative Concept]

Phrase: "amyotrophy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026846:Amyotrophy [Disease or Syndrome]

Phrase: "and"

Phrase: "dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.15: The genes for two forms of ADCA type I have been identified: spinocerebellar ataxia (SCA) 1 on chromosome 6p and SCA3, which is also responsible for Machado-Joseph disease (MJD), on chromosome 14q. 

Phrase: "The genes for two forms of ADCA type I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0314611:Gene type [Genetic Function]
   742   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ":"

Phrase: "spinocerebellar ataxia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0004134:Ataxia [Sign or Symptom]
   789 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(SCA) 1 on chromosome 6p"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0752120:Spinocerebellar Ataxia-1 [Disease or Syndrome]
   790   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   783   C0008651:Chromosome 1 [Cell Component]
   753   C0004134:Ataxia [Sign or Symptom]

Phrase: "and"

Phrase: "SCA3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024408:SCA3 [Disease or Syndrome]

Phrase: "which"

Phrase: "is"

Phrase: "also responsible for Machado-Joseph disease (MJD),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "on chromosome 14q."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327813:chromosome 14q [Nucleotide Sequence]
           14q
Processing 00000000.tx.16: Two other genes have been localized on chromosomes 12q (SCA2) and 16q (SCA4), and the existence of yet another is likely. 

Phrase: "Two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "localized on chromosomes 12q"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008633:Chromosomes [Cell Component]
   770   C0392752:Localized [Spatial Concept]
   770   C1520484:12q [Nucleotide Sequence]

Phrase: "(SCA2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "16q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520690:16q [Nucleotide Sequence]

Phrase: "(SCA4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752122:SCA4 [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the existence of yet"

Phrase: "another"

Phrase: "is"

Phrase: "likely."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]
Processing 00000000.tx.17: The association of macular degeneration with cerebellar ataxia is characteristic of ADCA type II, the gene for which has been mapped to the SCA7 locus on chromosome 3p. 

Phrase: "The association of macular degeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with cerebellar ataxia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007758:Cerebellar Ataxia [Sign or Symptom]
   861   C0004134:Ataxia [Sign or Symptom]
   861   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellar [Tissue]
   789 E C0234366:Ataxic [Sign or Symptom]

Phrase: "is"

Phrase: "characteristic of ADCA type II,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C3645613:Characteristic type [Intellectual Product]
   760   C1521970:Characteristic [Qualitative Concept]

Phrase: "the gene for which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "mapped to the SCA7 locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0752125:SCA7 [Disease or Syndrome]
   760   C1708726:Locus [Gene or Genome]
   726   C0024779:Map [Manufactured Object]
   726   C1706473:Map [Conceptual Entity]

Phrase: "on chromosome 3p."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0796477:chromosome 3p [Nucleotide Sequence]
           3p
   861   C1552216:3p [Body Part, Organ, or Organ Component]
Processing 00000000.tx.18: Finally, ADCA type III denotes a `pure' late onset cerebellar syndrome and has been mapped to chromosome 11cen (SCA5). 

Phrase: "Finally,"

Phrase: "ADCA type III"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0441731:Type III [Classification]
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "denotes"

Phrase: "a `pure' late onset cerebellar syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007760:Cerebellar syndrome [Disease or Syndrome]
   799   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   799   C0039082:Syndrome [Disease or Syndrome]
   799   C1707522:Cerebellar [Tissue]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "mapped to chromosome 11cen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0814036:chromosome map [Intellectual Product]
   770   C0008633:Chromosome [Cell Component]
   737   C0024779:Map [Manufactured Object]
   737   C1706473:Map [Conceptual Entity]

Phrase: "(SCA5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752123:SCA5 [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.19: SCA1 and SCA3/MJD share common molecular features with Huntington's disease (HD), dentatorubropallidoluysian atrophy (DRPLA) and spinobulbar muscular atrophy (SBMA), three other neurodegenerative disorders [reviewed in (3 ,5 )]: (i) the mutation is the expansion of a translated trinucleotide CAG repeat sequence; 

Phrase: "SCA1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0752120:SCA1 [Disease or Syndrome]

Phrase: "and"

Phrase: "SCA3/MJD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   923   C0024408:Machado-Joseph Disease [Disease or Syndrome]
           Joseph Disease
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "common molecular features with Huntington's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "(HD"

Phrase: ")"

Phrase: ","

Phrase: "dentatorubropallidoluysian atrophy (DRPLA)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   861   C0333641:Atrophy [Pathologic Function]
   789 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "and"

Phrase: "spinobulbar muscular atrophy (SBMA),"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0752353:Atrophy, Muscular, Spinobulbar [Disease or Syndrome]
           Spinobulbar Atrophy
   901   C0026846:Muscular Atrophy [Disease or Syndrome]
   827   C0026845:Muscular [Tissue]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0442025:Muscular [Spatial Concept]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C1995013:Muscles [Body Part, Organ, or Organ Component]

Phrase: "three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "other neurodegenerative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "["

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "in (3 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "]"

Phrase: ":"

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "the expansion of a translated trinucleotide CAG repeat sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   781   C0524894:Trinucleotide Repeat Expansion [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.20: (ii) there is a strong negative correlation between the number of CAG repeats and the age at onset; 

Phrase: "(ii"

Phrase: ")"

Phrase: "there"

Phrase: "is"

Phrase: "a strong negative correlation between the number of CAG repeats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.21: (iii) the CAG repeat is unstable particularly during paternal transmission, partially accounting for the anticipation phenomenon; 

Phrase: "(iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "the CAG repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205341:Repeat [Functional Concept]
   861   C1547730:Repeat [Temporal Concept]
   861   C1705914:Repeat [Conceptual Entity]

Phrase: "is"

Phrase: "unstable particularly during paternal transmission,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0040722:transmission [Idea or Concept]
   760   C0242781:Transmission [Pathologic Function]
   760   C0337493:Paternal [Qualitative Concept]
   760   C0443343:Unstable [Finding]
   760   C1521797:Transmission [Natural Phenomenon or Process]
   760   C1883468:UNSTABLE [Phenomenon or Process]
   760   C2347452:Paternal [Family Group]

Phrase: "partially"

Phrase: "accounting for the anticipation phenomenon"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0000938:Accounting [Occupational Activity]
   760   C0679106:anticipation [Mental Process]
   760   C1882365:Phenomenon [Phenomenon or Process]
   726 E C1551359:account [Idea or Concept]
   726 E C2741673:Account # [Clinical Attribute]
   726 E C2981730:Account [Classification]

Phrase: ";"
Processing 00000000.tx.22: and (iv) the normal, as well as the pathological protein, which contain an expanded polyglutamine tract, are expressed in the nervous system (6 -14 ). 

Phrase: "and ("

Phrase: "iv)"

Phrase: "the normal,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "as well as"

Phrase: "the pathological protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an expanded polyglutamine tract,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:Tract [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "expressed in the nervous system"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0027763:Nervous System [Body System]
   806   C0422837:NERVOUS SYSTEM [Finding]
   806   C1269560:Nervous system [Body System]
   760   C0027769:Nervous [Sign or Symptom]
   760   C0449913:System [Functional Concept]
   760   C0599851:Nervous [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   751 E C0205494:Neurologic [Qualitative Concept]
   714 E C0027855:Neurology [Biomedical Occupation or Discipline]

Phrase: "(6 -14"

Phrase: ")."
Processing 00000000.tx.23: Recently, Trottier and co-workers (13 ) reported that the monoclonal antibody 1C2 (mAb1C2) specifically recognizes long polyglutamine stretches, with a detection threshold that varies according to the protein. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "Trottier"

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(13"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the monoclonal antibody 1C2 (mAb1C2) specifically"

Phrase: "recognizes"

Phrase: "long polyglutamine stretches,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0270814:Stretches [Disease or Syndrome]
   793 E C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "with a detection threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: "that"

Phrase: "varies according to the protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0680240:according [Social Behavior]
   760   C1548673:Varies [Intellectual Product]
Processing 00000000.tx.24: Above the threshold, the intensity of the signal increases with the number of glutamines. 

Phrase: "Above the threshold,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449864:Threshold [Qualitative Concept]

Phrase: "the intensity of the signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0871362:signal intensity [Quantitative Concept]
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "increases with the number of glutamines."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0237753:*Number [Quantitative Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0449788:Number [Quantitative Concept]
   719   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.25: This antibody allowed the identification of expanded polyglutamine containing proteins of 150 and 130 kDa in lymphoblasts of patients with SCA2 and SCA7, respectively, suggesting that two additional subtypes of ADCA are caused by trinucleotide repeat expansion (13 ). 

Phrase: "This antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the identification of expanded polyglutamine containing proteins of 150"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0020792:Identification [Mental Process]
   742   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "130 kDa in lymphoblasts of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1532717:kDa [Quantitative Concept]

Phrase: "with SCA2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: "and"

Phrase: "SCA7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752125:SCA7 [Disease or Syndrome]

Phrase: "respectively,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that two additional subtypes of ADCA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449560:subtypes [Classification]

Phrase: "are"

Phrase: "caused by trinucleotide repeat expansion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0524894:Trinucleotide Repeat Expansion [Cell or Molecular Dysfunction]
   806   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205341:Repeat [Functional Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.26: In order to determine whether other proteins with polyglutamine expansions are involved in ADCAs, we have used mAb1C2 to analyze proteins extracted from lymphoblastoid cell lines of a large subset of patients. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "other proteins with polyglutamine expansions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "involved in ADCAs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1314939:Involved [Functional Concept]
   756   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   756   C1418447:ADCA [Gene or Genome]

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mAb1C2 to"

Phrase: "analyze"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracted from lymphoblastoid cell lines of a large subset of patients."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   756   C0007600:Cell lines [Cell]
   742   C0682526:lymphoblastoid cell line [Cell]
   738   C0007634:Cell [Cell]
   738   C0030705:Patients [Patient or Disabled Group]
   738   C0185115:Extracted [Therapeutic or Preventive Procedure]
   738   C0205132:lines [Spatial Concept]
   738   C0549177:Large [Quantitative Concept]
   738   C1269647:Cell [Cell]
   738   C1515021:Subset [Classification]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]
   738   C3541890:EXTRACTED [Finding]
   704 E C1550648:Line [Substance]
   704 E C1552960:Line [Quantitative Concept]
   704 E C2828366:Extract [Substance]
Processing 00000000.tx.27: We were able to evaluate the frequency of SCA2, characterized by the segregation of a 150 kDa protein. 

Phrase: "We"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the frequency of SCA2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "characterized by the segregation of a 150 kDa protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0080141:segregation [Social Behavior]
   742   C1532717:kDa [Quantitative Concept]
   742   C1880022:Characterized [Activity]
Processing 00000000.tx.28: A specific 130 kDa protein, expressed in the cerebral cortex, was observed in the majority of the ADCA type II kindreds. 

Phrase: "A specific 130 kDa protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed in the cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]

Phrase: "was"

Phrase: "observed in the majority of the ADCA type II kindreds."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   777   C0752125:ADCA, TYPE II [Disease or Syndrome]
   760   C0441730:Type II [Classification]
   739   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   739   C0332307:Type [Qualitative Concept]
   739   C0598429:kindreds [Qualitative Concept]
   739   C0680220:majority [Social Behavior]
   739   C1418447:ADCA [Gene or Genome]
   739   C1441672:Observed [Functional Concept]
   739   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.29: No evidence for new proteins with polyglutamine expansions was found either in the remaining ADCA families or in isolated cases with cerebellar ataxia (15 ). 

Phrase: "No evidence for new proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "with polyglutamine expansions"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "either in the remaining ADCA families"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0015576:Families [Family Group]
   753   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   753   C1418447:ADCA [Gene or Genome]
   753   C1527428:Remaining [Qualitative Concept]
   753   C1704727:Family [Conceptual Entity]

Phrase: "or in isolated cases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C1853237:Isolated cases [Finding]
   770   C0205409:Isolated [Functional Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "with cerebellar ataxia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007758:Cerebellar Ataxia [Sign or Symptom]
   861   C0004134:Ataxia [Sign or Symptom]
   861   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellar [Tissue]
   789 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.30: RESULTS The initial screening for proteins with expanded polyglutamine tracts using the mAb1C2 was performed only on the patients with the earliest ages at onset in each of 40 families with ADCA type I, 13 with ADCA type II and four with ADCA type III, in addition to seven isolated cases with cerebellar ataxia. 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "The initial screening for proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C1698960:screening [Intellectual Product]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]

Phrase: "with expanded polyglutamine tracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:tracts [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mAb1C2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "only on the patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "with the earliest ages at onset"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   886   C1833334:Early-onset [Finding]
   875   C0206132:age onset [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0332162:Onset [Qualitative Concept]

Phrase: "in each"

Phrase: "of 40 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "with ADCA type I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "13 with ADCA type II"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0752125:ADCA, TYPE II [Disease or Syndrome]
   806   C0441730:Type II [Classification]
   760   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C1418447:ADCA [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "four with ADCA type III,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0441731:Type III [Classification]
   760   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   760   C0205450:Four [Quantitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0439070:III [Intellectual Product]
   760   C1418447:ADCA [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]
   760   C1705160:III [Qualitative Concept]

Phrase: "in addition to seven isolated cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C1853237:Isolated cases [Finding]
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "with cerebellar ataxia."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007758:Cerebellar Ataxia [Sign or Symptom]
   861   C0004134:Ataxia [Sign or Symptom]
   861   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellar [Tissue]
   789 E C0234366:Ataxic [Sign or Symptom]
Processing 00000000.tx.31: Expansions of trinucleotide CAG repeats at the SCA1, SCA3/MJD and DRPLA loci had been excluded previously in all probands by PCR analysis (16 -18 ). 

Phrase: "Expansions of trinucleotide CAG"

Phrase: "repeats at the SCA1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205341:Repeat [Functional Concept]
   770   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0752120:SCA1 [Disease or Syndrome]
   770   C1547730:Repeat [Temporal Concept]
   770   C1705914:Repeat [Conceptual Entity]

Phrase: "SCA3/MJD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   923   C0024408:Machado-Joseph Disease [Disease or Syndrome]
           Joseph Disease
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "DRPLA loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1708726:Locus [Gene or Genome]
   734   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]

Phrase: "had"

Phrase: "been"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "previously in all probands"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0702111:probands [Organism Attribute]
   737 E C1948021:Proband [Family Group]

Phrase: "by PCR analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0200931:PCR analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "(16 -18"

Phrase: ")."
Processing 00000000.tx.32: Detection and analysis of SCA2 families Detection of the 150 kDa SCA2 protein. 

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "analysis of SCA2 families Detection of the 150 kDa SCA2 protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C1514534:Protein Analysis [Molecular Biology Research Technique]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]
Processing 00000000.tx.33: A 150 kDa protein was strongly detected in the selected patients from 16 of the 40 ADCA type I families (Fig. 1 A). 

Phrase: "A 150 kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "strongly"

Phrase: "detected in the selected patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726   C1707391:Select [Activity]

Phrase: "from 16"

Phrase: "of the 40 ADCA type I families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]

Phrase: "(Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.34: In six of them, linkage to the SCA2 locus has been established or suspected previously (19 -22 ). 

Phrase: "In six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "of them,"

Phrase: "linkage to the SCA2 locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023745:linkage [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "or"

Phrase: "suspected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332147:Suspected [Qualitative Concept]
  1000   C0750491:Suspected [Idea or Concept]
   966 E C1571873:Suspect [Idea or Concept]

Phrase: "previously"

Phrase: "(19 -22"

Phrase: ")."
Processing 00000000.tx.35: This strong 150 kDa contrasts with a much weaker band at the same size that was frequently observed in controls (Fig. 1 B, lane 1; Fig. 1 C, lane 6 and Fig. 1 D, lane 8). 

Phrase: "This strong 150 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "contrasts with a much weaker band"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]
   753   C1979874:Contrast [Qualitative Concept]
   719   C0004093:Weak [Sign or Symptom]
   719   C1762617:Weak [Qualitative Concept]

Phrase: "at the same size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "that"

Phrase: "was"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "observed in controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1441672:Observed [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 1 B,"

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "; Fig. 1 C,"

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "Fig. 1 D, lane 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0349966:Fig [Food]
   804   C1337208:FIG [Food]
   804   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.36: The presence of the SCA2 protein and its segregation with the disease was confirmed in 29 other patients from 10 of these 16 families, with ages at onset ranging from 13 to 57 years (Fig. 1 B). 

Phrase: "The presence of the SCA2 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its segregation with the disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0080141:segregation [Social Behavior]

Phrase: "was"

Phrase: "confirmed in 29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0521093:confirmed [Qualitative Concept]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "other patients from 10 of these 16 families,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030705:Patients [Patient or Disabled Group]

Phrase: "with ages at onset ranging"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1514721:Range [Quantitative Concept]
   779   C2348147:Range [Quantitative Concept]
   779   C3542016:Range [Intellectual Product]
   708   C0206132:age onset [Quantitative Concept]

Phrase: "from 13"

Phrase: "to 57 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.37: However, only the weak 150 kDa band was visible in two patients, with ages at onset of 46 (Fig. 1 C, lane 2) and 63 years (Table 1 1). 

Phrase: "However,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the weak 150 kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "visible in two patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205379:Visible [Qualitative Concept]

Phrase: "with ages at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "of 46"

Phrase: "(Fig. 1 C,"

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "63 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(Table 1 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0039224:Table [Manufactured Object]
   827   C1706073:Table [Medical Device]
   827   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.38: In addition, a strong signal was detected in an asymptomatic at risk individual, who was 33 years old and carried the haplotype segregating with the disease in his family (Fig. 1 B, lane 2). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a strong signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "detected in an asymptomatic at risk individual,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0027361:Individual [Population Group]
   748   C0035647:Risk [Qualitative Concept]
   748   C0231221:Asymptomatic [Finding]
   748   C0237401:Individual [Human]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "who"

Phrase: "was"

Phrase: "33 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "old"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580836:Old [Temporal Concept]

Phrase: "and"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "the haplotype segregating with the disease"

Phrase: "in his family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "(Fig. 1 B,"

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.39: Figure 1. 

Phrase: "Figure 1."
Processing 00000000.tx.40: Immunoblots of whole protein extracts from lymphoblastoid cell lines showing the SCA2 protein (arrow). 

Phrase: "Immunoblots of whole protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "extracts from lymphoblastoid cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   828   C0682526:lymphoblastoid cell line [Cell]
   806   C0007600:Cell lines [Cell]
   797   C0007592:Cell Extracts [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2828366:Extract [Substance]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the SCA2 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0531288:SCA2 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.41: A protein at ~230 kDa was visualized, with the same signal intensity, in all lymphoblastoid cell line extracts from controls and from patients. 

Phrase: "A protein at ~230 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1532717:kDa [Quantitative Concept]

Phrase: "was"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: ","

Phrase: "with the same signal intensity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0871362:signal intensity [Quantitative Concept]
   827   C0522510:Intensity [Qualitative Concept]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "in all lymphoblastoid cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0682526:lymphoblastoid cell line [Cell]
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "extracts from controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C2828366:Extract [Substance]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "and from patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.42: C = negative control, SCA3 = patient with SCA3/MJD mutation. 

Phrase: "C = negative control,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C1639518:% negative control [Quantitative Concept]
   901   C1947986:Negative Control [Conceptual Entity]
   827   C0205160:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1513916:Negative [Finding]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2825415:Negative [Conceptual Entity]
   827   C2825491:Negative [Qualitative Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "SCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024408:SCA3 [Disease or Syndrome]

Phrase: "= patient with SCA3/MJD mutation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:*^patient [Patient or Disabled Group]
Processing 00000000.tx.43: Age at onset of patients is indicated at the top of each line. 

Phrase: "Age at onset of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "indicated at the top of each line."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205132:Line [Spatial Concept]
   748   C1444656:Indicated [Finding]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704458:Top [Spatial Concept]
Processing 00000000.tx.44: (A) Detection of the SCA2 protein in nine unrelated patients. 

Phrase: "(A"

Phrase: ")"

Phrase: "Detection of the SCA2 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in nine unrelated patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.45: (B), (C) and (D) Segregation of the 150 kDa SCA2 protein in four families. 

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and ("

Phrase: "D)"

Phrase: "Segregation of the 150 kDa SCA2 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0080141:segregation [Social Behavior]

Phrase: "in four families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.46: Molecular weights are indicated in kDa at the left of autoradiograms (A) and (C). 

Phrase: "Molecular weights"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0026385:Molecular weights [Quantitative Concept]
   861   C0043100:Weights [Quantitative Concept]
   861   C1521991:Molecular [Qualitative Concept]
   827 E C0005910:weight [Organism Attribute]
   827 E C1305866:weight [Diagnostic Procedure]
   827 E C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "are"

Phrase: "indicated in kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1444656:Indicated [Finding]
   790   C1532717:kDa [Quantitative Concept]

Phrase: "at the left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "of autoradiograms (A)"

Phrase: "and ("

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.47: In seven families, visual inspection of the autoradiograms suggested that the intensity of the 150 kDa protein increased in successive generations as the age at onset decreased (Fig. 1 B). 

Phrase: "In seven families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "visual inspection of the autoradiograms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C2984756:VISUAL INSPECTION [Functional Concept]
   760   C0199219:Inspection [Functional Concept]
   760   C0234621:Visual [Functional Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the intensity of the 150 kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "increased in successive generations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0079411:Generations [Temporal Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C3146294:Generation [Activity]

Phrase: "as the age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.48: This was not the case, however, in all the families tested (Fig. 1 D). 

Phrase: "This"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "however,"

Phrase: "in all"

Phrase: "the families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(Fig. 1 D"

Phrase: ")."
Processing 00000000.tx.49: The intensity of the band also varied among patients with similar ages at onset from different kindreds (Fig. 1 A).

Phrase: "The intensity of the band also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0522510:Intensity [Qualitative Concept]

Phrase: "varied among patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "with similar ages at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0206132:age onset [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0332162:Onset [Qualitative Concept]

Phrase: "from different kindreds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598429:kindreds [Qualitative Concept]

Phrase: "(Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.50: Linkage analysis. 

Phrase: "Linkage analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0796345:linkage analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0023745:linkage [Molecular Function]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.51: Fourteen out of 16 SCA2 families were tested for linkage with markers D12S1340 and D12S1339 which flank the 1 cM SCA2 candidate region. 

Phrase: "Fourteen out of 16 SCA2 families"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0015576:Families [Family Group]
   753   C0439787:Out [Spatial Concept]
   753   C0752121:SCA2 [Disease or Syndrome]
   753   C0849355:Out [Qualitative Concept]
   753   C1334353:SCA-2 [Gene or Genome]
   753   C1704727:Family [Conceptual Entity]
   753   C1705387:SCA-2 [Gene or Genome]

Phrase: "were"

Phrase: "tested for linkage"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0023745:linkage [Molecular Function]
   790   C0392366:tested [Intellectual Product]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "with markers D12S1340"

Phrase: "and"

Phrase: "D12S1339"

Phrase: "which"

Phrase: "flank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:Flank [Body Location or Region]

Phrase: "the 1 cM SCA2 candidate region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0017446:Region [Geographic Area]
   804   C0205147:Region [Spatial Concept]
   733 E C0205276:Regional [Spatial Concept]
   733 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.52: Maximum lod scores of 9.54 and 12.31 were obtained at 0.05 and 0.00 recombination fractions for markers D12S1339 and D12S1340, respectively. 

Phrase: "Maximum lod scores of 9.54"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0023956:Scores, Lod [Quantitative Concept]
   753   C0449820:Scores [Quantitative Concept]
   753   C0806909:Maximum [Quantitative Concept]
   753   C1552615:maximum [Quantitative Concept]
   753   C2247199:Lod [Molecular Function]
   753   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "and"

Phrase: "12.31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "were"

Phrase: "obtained at 0.05"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "0.00 recombination fractions for markers D12S1339"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1514799:Recombination Fraction [Quantitative Concept]
   748   C1264633:Fractions [Quantitative Concept]
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "D12S1340,"

Phrase: "respectively."
Processing 00000000.tx.53: Using haplotype reconstruction, recombination events with the centromeric marker D12S1339 were detected in two patients. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "haplotype reconstruction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020912:Reconstruction [Machine Activity]
   861   C0524865:Reconstruction [Therapeutic or Preventive Procedure]

Phrase: "recombination events with the centromeric marker D12S1339"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441471:Events [Event]
   748   C3541888:Events [Classification]

Phrase: "were"

Phrase: "detected in two patients."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205448:Two [Quantitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.54: One of these events was confirmed with the more centromeric markers D12S105 and D12S84 (data not shown). 

Phrase: "One of these events"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "confirmed with the more centromeric markers D12S105"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0521093:confirmed [Qualitative Concept]
   748   C0750484:Confirmed [Idea or Concept]
   714   C0005516:Marker [Clinical Attribute]
   714 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "D12S84"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.55: Table 1 Detection of protein containing expanded polyglutamine tracts with mAb1C2 in whole protein extracts Detection by mAb1C2 No. of patients Mean age at onset (range) In SCA2 families Positive (150 kDa) 45 33.4 +- 12.1 (13-57) Negative 2 54.5 +- 12.0 (46-63) In ADCA type II kindreds Positive (130 kDa)a 12 18.9 +- 11.1 (5-43) Negativeb 8 37.8 +- 9.5 (27-55) aA 150 kDa band was also detected in three patients, and a 180 kDa band in one.bIncluding one individual with a strongly labeled 150 kDa protein.

Phrase: "Table 1 Detection of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "expanded polyglutamine tracts with mAb1C2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1185740:tracts [Body Part, Organ, or Organ Component]

Phrase: "in whole protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0444667:Whole [Quantitative Concept]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "Detection by mAb1C2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0430425:Antibody detection [Laboratory Procedure]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "No."

Phrase: "of patients Mean age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0206132:age onset [Quantitative Concept]
   804   C0001779:Age [Organism Attribute]
   804   C0332162:Onset [Qualitative Concept]

Phrase: "(range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "In SCA2 families Positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "(150 kDa) 45 33.4 +- 12.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1532717:kDa [Quantitative Concept]

Phrase: "(13-57"

Phrase: ")"

Phrase: "Negative 2 54.5 +- 12.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0205160:Negative [Qualitative Concept]
   799   C1513916:Negative [Finding]
   799   C2825415:Negative [Conceptual Entity]
   799   C2825491:Negative [Qualitative Concept]

Phrase: "(46-63"

Phrase: ")"

Phrase: "In ADCA type II kindreds Positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0439178:% Positive [Quantitative Concept]
   804   C1446409:Positive [Qualitative Concept]
   804   C1514241:Positive [Finding]
   804   C2825490:Positive [Qualitative Concept]

Phrase: "(130 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "a 12 18.9 +- 11.1"

Phrase: "(5-43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "Negativeb 8 37.8 +- 9.5"

Phrase: "(27-55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: "aA 150 kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "also"

Phrase: "detected in three patients,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205449:Three [Quantitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "a 180 kDa band in one.bIncluding one individual"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0230715:A band [Cell Component]
   742   C0175723:Band [Medical Device]
   742   C0439645:Band [Spatial Concept]
   742   C1521913:band [Cell Component]

Phrase: "with a strongly"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "150 kDa protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.56: Anticipation in age at onset in SCA2 families. 

Phrase: "Anticipation in age at onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679106:anticipation [Mental Process]

Phrase: "in SCA2 families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.57: The mean age at onset, known for 100 SCA2 patients, was 34.6 +- 14.0 (range 8-67) years and did not differ significantly between men (34.2 +- 13.4 years, n = 59) and women (35.1 +- 14.9 years, n = 41). 

Phrase: "The mean age at onset,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0206132:age onset [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0332162:Onset [Qualitative Concept]

Phrase: "known for 100 SCA2 patients,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0205309:Known [Qualitative Concept]
   760   C0752121:SCA2 [Disease or Syndrome]
   760   C1334353:SCA-2 [Gene or Genome]
   760   C1705387:SCA-2 [Gene or Genome]

Phrase: "was"

Phrase: "34.6 +- 14.0"

Phrase: "(range 8-67"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439234:years [Temporal Concept]
   966 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ"

Phrase: "significantly between men (34.2 +- 13.4 years,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0025268:MEN 2 [Neoplastic Process]
   744   C0025266:Men [Population Group]
   744   C0439234:years [Temporal Concept]
   711 E C0024554:MAN [Finding]
   711 E C0086418:Man [Human]
   711 E C0439508:/year [Temporal Concept]

Phrase: "n = 59"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "(35.1 +- 14.9 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "n = 41"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.58: There was no difference according to the sex of the transmitting parent: 33.1 +- 15.2 years (n = 50) and 34.7 +- 11.9 years (n = 46) between paternal and maternal transmissions, respectively. 

Phrase: "There"

Phrase: "was"

Phrase: "no difference according to the sex of the transmitting parent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0036866:Sex Difference [Organism Attribute]
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: ":"

Phrase: "33.1 +- 15.2 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "(n = 50"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "34.7 +- 11.9 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "(n = 46"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "between paternal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337493:Paternal [Qualitative Concept]
  1000   C2347452:Paternal [Family Group]

Phrase: "and"

Phrase: "maternal transmissions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C3274499:Maternal Transmission [Pathologic Function]
   827   C0040722:transmission [Idea or Concept]
   827   C0242781:Transmission [Pathologic Function]
   827   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "respectively."
Processing 00000000.tx.59: In the 48 parent-child pairs, for which the ages at onset were known, a mean anticipation of 14.7 +- 13.1 years (range -13 to +52) was observed (P<0.001). 

Phrase: "In the 48 parent-child pairs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709450:Pair [Qualitative Concept]

Phrase: "for which"

Phrase: "the ages at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "were"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "a mean anticipation of 14.7 +- 13.1 years"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0679106:anticipation [Mental Process]

Phrase: "(range -13 to +52"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1514721:Range [Quantitative Concept]
   812   C2348147:Range [Quantitative Concept]
   812   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.60: Anticipation was more marked, although not significantly, in paternal (16.1 +- 14.6 years, n = 26) compared with maternal (13.1 +- 11.3 years, n = 22) transmissions. 

Phrase: "Anticipation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679106:anticipation [Mental Process]

Phrase: "was"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: ","

Phrase: "although"

Phrase: "not significantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "in paternal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337493:Paternal [Qualitative Concept]
  1000   C2347452:Paternal [Family Group]

Phrase: "(16.1 +- 14.6 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "n = 26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "compared with maternal"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1707455:Compared [Activity]
   790   C2347083:Maternal [Family Group]
   734 E C0026591:Mother [Family Group]
   706 E C1826438:MATER [Gene or Genome]

Phrase: "(13.1 +- 11.3 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "n = 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "transmissions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0040722:transmission [Idea or Concept]
   966   C0242781:Transmission [Pathologic Function]
   966   C1521797:Transmission [Natural Phenomenon or Process]
Processing 00000000.tx.61: Characteristics of the SCA7 protein in ADCA type II families Thirteen families with the specific ADCA type II phenotype were analyzed. 

Phrase: "Characteristics of the SCA7 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "in ADCA type II families Thirteen families"

Phrase: "with the specific ADCA type II phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031437:Phenotype [Organism Attribute]
   804   C1285572:Phenotype [Laboratory Procedure]

Phrase: "were"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.62: Their clinical features were similar to those found in previous reports (23 ,24 ). 

Phrase: "Their clinical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "were"

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "found in previous reports"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0150312:Found [Quantitative Concept]
   770   C0205156:Previous [Temporal Concept]
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   770   C1552607:previous [Temporal Concept]
   737 E C0243095:Find [Finding]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(23 ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.63: The mean age at onset was 27.3 +- 15.2 years (range 1.5-70; n = 49) and was similar in men (24.01 +- 15.9, n = 26) and women (31.0 +- 13.9, n = 23). 

Phrase: "The mean age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0206132:age onset [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0332162:Onset [Qualitative Concept]

Phrase: "was"

Phrase: "27.3 +- 15.2 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "(range 1.5-70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1514721:Range [Quantitative Concept]
   812   C2348147:Range [Quantitative Concept]
   812   C3542016:Range [Intellectual Product]

Phrase: "; n = 49"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "similar in men (24.01 +- 15.9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "n = 26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "(31.0 +- 13.9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450355:31 [Intellectual Product]

Phrase: "n = 23"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0450348:23 [Quantitative Concept]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.64: A mean 18.2 +- 13.1 years (range -10 to +45) anticipation was observed in 22 parent-child couples, and was significantly more marked in paternal (23.1 +- 15.6 years, n = 8) compared with maternal (15.3 +- 11.1 years, n = 14) transmissions (P<0.05). 

Phrase: "A mean 18.2 +- 13.1 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0439234:years [Temporal Concept]
   762 E C0439508:/year [Temporal Concept]

Phrase: "(range -10 to +45"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1514721:Range [Quantitative Concept]
   812   C2348147:Range [Quantitative Concept]
   812   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "anticipation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679106:anticipation [Mental Process]

Phrase: "was"

Phrase: "observed in 22 parent-child couples,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0260096:parent child [Family Group]
   753   C0008059:Child [Age Group]
   753   C0010222:Couples [Family Group]
   753   C0030551:parent [Family Group]
   753   C0680063:CHILD [Family Group]
   753   C1441672:Observed [Functional Concept]
   753   C2699423:Parent [Conceptual Entity]
   719 E C1948027:Couple [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "significantly more"

Phrase: "marked in paternal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0337493:Paternal [Qualitative Concept]
   790   C0522501:Marked [Qualitative Concept]
   790   C1706089:Marked [Qualitative Concept]
   790   C2347452:Paternal [Family Group]

Phrase: "(23.1 +- 15.6 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "compared with maternal"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1707455:Compared [Activity]
   790   C2347083:Maternal [Family Group]
   734 E C0026591:Mother [Family Group]
   706 E C1826438:MATER [Gene or Genome]

Phrase: "(15.3 +- 11.1 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "n = 14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "transmissions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0040722:transmission [Idea or Concept]
   966   C0242781:Transmission [Pathologic Function]
   966   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "(P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.65: In six of the 13 ADCA type II families, a specific 130 kDa band was observed in 12 patients with ages at onset ranging from 5 to 43 years (Table 1 and Fig. 2 , individuals SAL-306-001, Rbt-002-029 and Rbt-002-027). 

Phrase: "In six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "of the 13 ADCA type II families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]

Phrase: "a specific 130 kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "observed in 12 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1441672:Observed [Functional Concept]

Phrase: "with ages at onset ranging"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1514721:Range [Quantitative Concept]
   779   C2348147:Range [Quantitative Concept]
   779   C3542016:Range [Intellectual Product]
   708   C0206132:age onset [Quantitative Concept]

Phrase: "from 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "to 43 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 2 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "individuals SAL-306-001,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]
   756   C0036140:Salt [Chemical Viewed Structurally]
   756   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   756   C0206136:Salt [Food,Inorganic Chemical]
   719 E C1537053:salty [Qualitative Concept]
   701 E C0678584:saltiness [Qualitative Concept]

Phrase: "Rbt-002-029"

Phrase: "and"

Phrase: "Rbt-002-027"

Phrase: ")."
Processing 00000000.tx.66: The co-segregation of the protein and the disease could be observed in two of these kindreds. 

Phrase: "The co-segregation of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0080141:segregation [Social Behavior]

Phrase: "and"

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "could"

Phrase: "be"

Phrase: "observed in two of these kindreds."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205448:Two [Quantitative Concept]
   753   C0598429:kindreds [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
Processing 00000000.tx.67: In some patients from SCA7-linked families (24 ), a 150 kDa band (n = 3) or a 180 kDa (n = 1) were detected in addition to the 130 kDa protein (Fig. 2 ). 

Phrase: "In some patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "from SCA7-linked families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "a 150 kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "a 180 kDa (n = 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "detected in addition to the 130 kDa protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0442726:Detected [Finding]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1532717:kDa [Quantitative Concept]
   744   C1883712:Addition [Functional Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.68: Their presence was not correlated with an early age at onset (range 5-43 years). 

Phrase: "Their presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correlated with an early age at onset"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0206132:Onset Age [Quantitative Concept]
   774   C1833334:Early-onset [Finding]
   748   C0001779:Age [Organism Attribute]
   748   C0332162:Onset [Qualitative Concept]
   748   C1279919:Early [Temporal Concept]
   748   C1707520:Correlated [Qualitative Concept]

Phrase: "(range 5-43 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.69: The 130 kDa protein was not detected in eight patients, with ages at onset from 27 to 55 years. 

Phrase: "The 130 kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in eight patients,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205454:Eight [Quantitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with ages at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "from 27"

Phrase: "to 55 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.70: Interestingly, in one of these negative patients with an age at onset of 34 years (Rbt-007-016), a strong signal of higher molecular weight was present at 150 kDa (Fig. 2 ). 

Phrase: "Interestingly,"

Phrase: "in one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of these negative patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with an age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "of 34 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(Rbt-007-016"

Phrase: ")"

Phrase: ","

Phrase: "a strong signal of higher molecular weight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "present at 150 kDa (Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.71: Figure 2. 

Phrase: "Figure 2."
Processing 00000000.tx.72: Immunoblot of protein extracts from ADCA type II patients. 

Phrase: "Immunoblot of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "extracts from ADCA type II patients."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   820   C0752125:ADCA, TYPE II [Disease or Syndrome]
   790   C0441730:Type II [Classification]
   767   C1550335:Patient type [Classification]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   753   C0332307:Type [Qualitative Concept]
   753   C1418447:ADCA [Gene or Genome]
   753   C1547052:*Type [Quantitative Concept]
   753   C2828366:Extract [Substance]
Processing 00000000.tx.73: Electrophoresis was carried out on 150 [mu]g of protein from brain cortex and 50 [mu]g from lymphoblastoid cell line extracts. 

Phrase: "Electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out on 150"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "[mu]g of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1532982:mU/g [Quantitative Concept]
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: "from brain cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "50"

Phrase: "[mu]g from lymphoblastoid cell line extracts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1532982:mU/g [Quantitative Concept]
   774   C0524983:G cell [Cell]
   748   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.74: C = negative control, SCA2 = patient with the 150 kDa SCA2 protein, LCLs = lymphoblastoid cell lines. 

Phrase: "C = negative control,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C1639518:% negative control [Quantitative Concept]
   901   C1947986:Negative Control [Conceptual Entity]
   827   C0205160:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1513916:Negative [Finding]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2825415:Negative [Conceptual Entity]
   827   C2825491:Negative [Qualitative Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "SCA2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: "= patient with the 150 kDa SCA2 protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:*^patient [Patient or Disabled Group]

Phrase: "LCLs"

Phrase: "= lymphoblastoid cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   966   C0682526:lymphoblastoid cell line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.75: Molecular weights are indicated in kDa at the left of the immunoblot. 

Phrase: "Molecular weights"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0026385:Molecular weights [Quantitative Concept]
   861   C0043100:Weights [Quantitative Concept]
   861   C1521991:Molecular [Qualitative Concept]
   827 E C0005910:weight [Organism Attribute]
   827 E C1305866:weight [Diagnostic Procedure]
   827 E C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "are"

Phrase: "indicated in kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1444656:Indicated [Finding]
   790   C1532717:kDa [Quantitative Concept]

Phrase: "at the left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "of the immunoblot."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.76: The typical SCA7 130 kDa protein is seen in individuals SAL-306-001, Rbt-002-029 and Rbt-002-027. 

Phrase: "The typical SCA7 130 kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "seen in individuals SAL-306-001,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0205397:Seen [Qualitative Concept]
   719   C0027361:Individual [Population Group]
   719 E C0042789:see [Organism Function]
   719   C0237401:Individual [Human]
   719 E C1947903:See [Activity]

Phrase: "Rbt-002-029"

Phrase: "and"

Phrase: "Rbt-002-027."
Processing 00000000.tx.77: Proteins of 180 and 150 kDa are seen in patients Rbt-002-026 and Rbt-007-016, although they are from SCA7-linked families (24). 

Phrase: "Proteins of 180"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "150 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "are"

Phrase: "seen in patients Rbt-002-026"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0205397:Seen [Qualitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "and"

Phrase: "Rbt-007-016,"

Phrase: "although"

Phrase: "they"

Phrase: "are from SCA7-linked families"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0015576:Families [Family Group]
   760   C0752125:SCA7 [Disease or Syndrome]
   760   C1551058:Are [Quantitative Concept]
   760   C1704727:Family [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.78: Only the typical 130 kDa band is detected in the brain cortex of patient SAL-313-016, as compared with LCLs. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the typical 130 kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "detected in the brain cortex of patient SAL-313-016,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0007776:Cortex [Body Part, Organ, or Organ Component]
   739   C0030705:*^patient [Patient or Disabled Group]
   739   C0442726:Detected [Finding]
   739   C1176472:Cortex [Body Part, Organ, or Organ Component]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1511790:Detected [Therapeutic or Preventive Procedure]
   739   C2700441:Cortex [Plant]

Phrase: "as"

Phrase: "compared with LCLs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]
Processing 00000000.tx.79: The absence of a detectable 130 kDa protein in patients from the seven remaining families might reflect a low expression. 

Phrase: "The absence of a detectable 130 kDa protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332197:absence [Quantitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "from the seven remaining families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "might"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a low expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.80: The hypothesis was tested by preparing nuclear fractions in which the SCA7 protein, which is located in the nucleus (13 ), should be enriched. 

Phrase: "The hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "was"

Phrase: "tested by preparing nuclear fractions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0392366:tested [Intellectual Product]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   726   C1521827:Prepare [Functional Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "in which"

Phrase: "the SCA7 protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "is"

Phrase: "located in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "should"

Phrase: "be"

Phrase: "enriched."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0359583:enriched [Food]
Processing 00000000.tx.81: A weak band at 130 kDa was observed for three patients in three of the seven remaining ADCA type II families. 

Phrase: "A weak band at 130 kDa"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "observed for three patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205449:Three [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "in three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "of the seven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205453:Seven [Quantitative Concept]

Phrase: "remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1527428:Remaining [Qualitative Concept]

Phrase: "ADCA type II families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.82: In two patients, the low intensity could not be explained only by a late age at onset; 

Phrase: "In two patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "the low intensity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205251:low [Qualitative Concept]
   861   C0522510:Intensity [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "explained"

Phrase: "only by a late age at onset"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0206132:Onset Age [Quantitative Concept]
   748   C0001779:Age [Organism Attribute]
   748   C0205087:Late [Temporal Concept]
   748   C0205171:Only [Quantitative Concept]
   748   C0332162:Onset [Qualitative Concept]
   748   C1720467:Only [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.83: they were 20 and 22 years old. 

Phrase: "they"

Phrase: "were"

Phrase: "20"

Phrase: "and"

Phrase: "22 years old."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]
Processing 00000000.tx.84: In the remaining four kindreds (age at onset range 18-48 years), there was no evidence of 130, 150 or 180 kDa proteins containing an expanded polyglutamine tract. 

Phrase: "In the remaining four kindreds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0598429:kindreds [Qualitative Concept]

Phrase: "(age at onset range 18-48 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   893   C1510829:Age-Years [Temporal Concept]
   795   C0439234:years [Temporal Concept]
   762 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "was"

Phrase: "no evidence of 130,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "150"

Phrase: "or"

Phrase: "180 kDa proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an expanded polyglutamine tract."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:Tract [Body Part, Organ, or Organ Component]
Processing 00000000.tx.85: These four families were not informative for linkage analysis; 

Phrase: "These four families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "were"

Phrase: "not informative for linkage analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986490:Informative [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.86: however, recombination events between the disease and SCA7 closely linked markers (24 ) were not observed (data not shown). 

Phrase: "however,"

Phrase: "recombination events between the disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441471:Events [Event]
   760   C3541888:Events [Classification]

Phrase: "and"

Phrase: "SCA7 closely linked markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0005516:Marker [Clinical Attribute]

Phrase: "(24"

Phrase: ")"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: Finally, in one deceased patient (SAL-313-016) from whom brain tissue could be obtained, two proteins of 130 and 150 kDa were detected in lymphoblasts, but only the 130 kDa pathological protein was expressed in the cerebral cortex (Fig. 2 ). 

Phrase: "Finally,"

Phrase: "in one deceased patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(SAL-313-016"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   771   C0036140:Salt [Chemical Viewed Structurally]
   771   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   771   C0206136:Salt [Food,Inorganic Chemical]
   734 E C1537053:salty [Qualitative Concept]
   716 E C0678584:saltiness [Qualitative Concept]

Phrase: ")"

Phrase: "from whom brain tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0440746:Brain tissue [Tissue]
  1000   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "two proteins of 130"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "150 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "were"

Phrase: "detected in lymphoblasts,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0229613:Lymphoblasts [Cell]
   790   C0442726:Detected [Finding]
   790   C1167770:Lymphoblasts [Laboratory Procedure]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the 130 kDa pathological protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "expressed in the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.88: Absence of other detectable disease-specific pathological proteins with polyglutamine expansion There were no detectable proteins with expanded polyglutamine stretches in the lymphoblastoid cell lines from 21 of the 24 remaining ADCA type I families, nor in those with ADCA type III or isolated cases with cerebellar ataxia. 

Phrase: "Absence of other detectable disease-specific pathological proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332197:absence [Quantitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]

Phrase: "with polyglutamine expansion There"

Phrase: "were"

Phrase: "no detectable proteins with expanded polyglutamine stretches"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the lymphoblastoid cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   966   C0682526:lymphoblastoid cell line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "from 21"

Phrase: "of the 24 remaining ADCA type I families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0015576:Families [Family Group]
   799   C1704727:Family [Conceptual Entity]
   716 E C0241888:Familial [Functional Concept]

Phrase: "nor in those with ADCA type III"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0441731:Type III [Classification]
   748   C0028423:NOR [Geographic Area]
   748   C0028609:NOR [Cell Component]
   748   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0439070:III [Intellectual Product]
   748   C1418447:ADCA [Gene or Genome]
   748   C1513854:NOR [Mammal]
   748   C1547052:*Type [Quantitative Concept]
   748   C1705160:III [Qualitative Concept]

Phrase: "or"

Phrase: "isolated cases with cerebellar ataxia."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C1853237:Isolated cases [Finding]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.89: In three patients with ADCA type I, no conclusion could be drawn since the intensity of the 150 kDa band was intermediate between the normal control signal and the more intense signal corresponding to the SCA2 protein. 

Phrase: "In three patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with ADCA type I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "no conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "could"

Phrase: "be"

Phrase: "drawn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013113:Draw [Intellectual Product]

Phrase: "since"

Phrase: "the intensity of the 150 kDa band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "intermediate between the normal control signal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205103:Intermediate [Spatial Concept]
   753   C1550465:intermediate [Idea or Concept]
   753   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "the more intense signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "corresponding to the SCA2 protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0531288:SCA2 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0752121:SCA2 [Disease or Syndrome]
   760   C1334353:SCA-2 [Gene or Genome]
   760   C1705387:SCA-2 [Gene or Genome]
Processing 00000000.tx.90: A 190 and a strong 230 kDa protein, as well as the TATA-binding protein (TBP) at ~50 kDa, were detected in lymphoblasts of all patients and controls, as already reported (13 ). 

Phrase: "A 190"

Phrase: "and"

Phrase: "a strong 230 kDa protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "the TATA-binding protein (TBP) at ~50 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1532717:kDa [Quantitative Concept]

Phrase: "were"

Phrase: "detected in lymphoblasts of all patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0229613:Lymphoblasts [Cell]
   753   C0442726:Detected [Finding]
   753   C1167770:Lymphoblasts [Laboratory Procedure]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "as"

Phrase: "already"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.91: In order to determine whether an unstable mutation could be excluded in the 21 remaining ADCA type I families, anticipation was evaluated. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "an unstable mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "could"

Phrase: "be"

Phrase: "excluded in the 21 remaining ADCA type I families,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   764   C0441729:Type I [Classification]
   742   C0015576:Families [Family Group]
   742   C0021966:I- [Inorganic Chemical]
   742   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0332307:Type [Qualitative Concept]
   742   C1418447:ADCA [Gene or Genome]
   742   C1527428:Remaining [Qualitative Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1554077:Excluded [Idea or Concept]
   742   C1704727:Family [Conceptual Entity]
   742   C2828389:Excluded [Activity]
   708 E C0332196:Exclude [Functional Concept]

Phrase: "anticipation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679106:anticipation [Mental Process]

Phrase: "was"

Phrase: "evaluated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]
Processing 00000000.tx.92: Mean age at onset was 33.3 +- 12.9 years (n = 61), and differed significantly between those who inherited the disease from their father (28.8 +- 10.3 years, n = 26) and those who received it from their mother (34.8 +- 13.2 years, n = 27) (P<0.05). 

Phrase: "Mean age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0206132:age onset [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0332162:Onset [Qualitative Concept]

Phrase: "was"

Phrase: "33.3 +- 12.9 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "(n = 61"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "differed"

Phrase: "significantly between those"

Phrase: "who"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "the disease from their father"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(28.8 +- 10.3 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "n = 26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "those who"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "it from their mother"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0026591:Mother [Family Group]
   715 E C1826438:MATER [Gene or Genome]
   715 E C2347083:Maternal [Family Group]

Phrase: "(34.8 +- 13.2 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "n = 27"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "(P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.93: The mean anticipation in 28 parent-child couples was 9.9 +- 13.1 years and differed, although not significantly (P = 0.055), according to the gender of the transmitting parent (13.7 +- 14.2 years, n = 15 and 5.4 +- 10.6 years, n = 13 for paternal and maternal inheritance, respectively). 

Phrase: "The mean anticipation in 28 parent-child couples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0679106:anticipation [Mental Process]

Phrase: "was"

Phrase: "9.9 +- 13.1 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "differed,"

Phrase: "although"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "(P = 0.055"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "according to the gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "of the transmitting parent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030551:parent [Family Group]
   861   C2699423:Parent [Conceptual Entity]

Phrase: "(13.7 +- 14.2 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "n = 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "5.4 +- 10.6 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "n = 13 for paternal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0337493:Paternal [Qualitative Concept]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441922:N+ [Intellectual Product]
   770   C1553036:[n] [Quantitative Concept]
   770   C2347452:Paternal [Family Group]

Phrase: "and"

Phrase: "maternal inheritance,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0242538:Inheritance [Quantitative Concept]
   861   C0728826:Inheritance [Functional Concept]
   861   C2347083:Maternal [Family Group]
   805 E C0026591:Mother [Family Group]
   777 E C1826438:MATER [Gene or Genome]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.94: In two of these negative kindreds, linkage to SCA4 and SCA5 could be excluded (data not shown). 

Phrase: "In two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "of these negative kindreds,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598429:kindreds [Qualitative Concept]

Phrase: "linkage to SCA4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023745:linkage [Molecular Function]

Phrase: "and"

Phrase: "SCA5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752123:SCA5 [Disease or Syndrome]

Phrase: "could"

Phrase: "be"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.95: The remaining families were not informative for linkage analysis. 

Phrase: "The remaining families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "were"

Phrase: "not informative for linkage analysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986490:Informative [Qualitative Concept]
Processing 00000000.tx.96: DISCUSSION Systematic screening for proteins with expanded polyglutamine tracts in lymphoblastoid cell lines from a large series of families with various forms of ADCA or isolated cerebellar ataxia permitted the detection of new SCA2 families in which the abnormal protein segregated, and the analysis of kindreds with the ADCA type II phenotype. 

Phrase: "DISCUSSION Systematic screening for proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C1698960:screening [Intellectual Product]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]

Phrase: "with expanded polyglutamine tracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:tracts [Body Part, Organ, or Organ Component]

Phrase: "in lymphoblastoid cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   966   C0682526:lymphoblastoid cell line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "from a large series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "of families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with various forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "of ADCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
  1000   C1418447:ADCA [Gene or Genome]

Phrase: "or"

Phrase: "isolated cerebellar ataxia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0007758:Cerebellar Ataxia [Sign or Symptom]
   827   C0004134:Ataxia [Sign or Symptom]
   827   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   827   C1707522:Cerebellar [Tissue]
   755 E C0234366:Ataxic [Sign or Symptom]

Phrase: "permitted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0329040:permitted [Fish]
   966 E C0023636:Permit [Regulation or Law]

Phrase: "the detection of new SCA2 families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in which"

Phrase: "the abnormal protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0311448:Abnormal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "segregated"

Phrase: ","

Phrase: "and"

Phrase: "the analysis of kindreds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "with the ADCA type II phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031437:Phenotype [Organism Attribute]
   812   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.97: An intensely labeled 150 kDa protein was detected in 16 families for which linkage to markers D12S1339 and D12S1340 was then established. 

Phrase: "An intensely"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "150 kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected in 16 families"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015576:Families [Family Group]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1704727:Family [Conceptual Entity]

Phrase: "for which linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "to markers D12S1339"

Phrase: "and"

Phrase: "D12S1340"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.98: These results demonstrate that the 150 kDa signal corresponds to the SCA2 protein which carries an expanded polyglutamine tract. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the 150 kDa signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "corresponds to the SCA2 protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0531288:SCA2 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0752121:SCA2 [Disease or Syndrome]
   760   C1334353:SCA-2 [Gene or Genome]
   760   C1705387:SCA-2 [Gene or Genome]

Phrase: "which"

Phrase: "carries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:Carries [Finding]

Phrase: "an expanded polyglutamine tract."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:Tract [Body Part, Organ, or Organ Component]
Processing 00000000.tx.99: Taking into account the relative frequencies of SCA1 (13%) and SCA3 (28%) in this sample (18 ), the frequency of the SCA2 mutation was evaluated at ~24%. 

Phrase: "Taking into"

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "the relative frequencies of SCA1"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "(13%"

Phrase: ")"

Phrase: "and"

Phrase: "SCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024408:SCA3 [Disease or Syndrome]

Phrase: "(28%"

Phrase: ")"

Phrase: "in this sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "the frequency of the SCA2 mutation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C3178846:Mutation Frequency [Qualitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "at ~24%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516077:At [Spatial Concept]
Processing 00000000.tx.100: In this series, SCA2 was more frequent than SCA1, the first mapped and identified triplet repeat responsible for an ADCA. 

Phrase: "In this series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "SCA2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: "was"

Phrase: "more frequent than SCA1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332183:Frequent [Temporal Concept]

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "mapped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0024779:Map [Manufactured Object]
   966   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "identified triplet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041095:Triplet [Family Group]
   861   C0205174:Triplet [Quantitative Concept]

Phrase: "repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205341:Repeat [Functional Concept]
  1000   C1547730:Repeat [Temporal Concept]
  1000   C1705914:Repeat [Conceptual Entity]

Phrase: "responsible for an ADCA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.101: As previously reported in SCA2 kindreds (18 ,19 ,21 ), the group of SCA2 patients differed from SCA1 and SCA3/MJD groups by higher frequencies of decreased or abolished reflexes of the lower limbs, fasciculations, slow eye movements and tremor, and by a lower frequency of extensor plantar responses (data not shown). 

Phrase: "As"

Phrase: "previously"

Phrase: "reported in SCA2 kindreds"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0598429:kindreds [Qualitative Concept]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C0752121:SCA2 [Disease or Syndrome]
   770   C1334353:SCA-2 [Gene or Genome]
   770   C1705387:SCA-2 [Gene or Genome]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(18 ,"

Phrase: "19 ,"

Phrase: "21"

Phrase: ")"

Phrase: ","

Phrase: "the group of SCA2 patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "differed from SCA1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0752120:SCA1 [Disease or Syndrome]

Phrase: "and"

Phrase: "SCA3/MJD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   923   C0024408:Machado-Joseph Disease [Disease or Syndrome]
           Joseph Disease
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "groups by higher frequencies of decreased"
Meta Candidates (Total=22; Excluded=6; Pruned=0; Remaining=16)
   756   C0205212:High frequency [Temporal Concept]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0439603:Frequencies [Temporal Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   742   C2732728:Decreased height [Finding]
   725 E C0424641:height decrease [Finding]
   719   C0205250:High [Qualitative Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719   C1299351:High [Qualitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "or"

Phrase: "abolished reflexes of the lower limbs,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0034929:reflexes [Organ or Tissue Function]
   753   C0596002:Reflexes [Finding]
   719 E C0439840:reflex [Organ or Tissue Function]

Phrase: "fasciculations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015644:Fasciculations [Sign or Symptom]

Phrase: "slow eye movements"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C3551012:Slow eye movements [Finding]
   901   C0015413:Eye Movements [Organ or Tissue Function]
   901   C0702182:eye movement [Finding]
   827   C0015392:Eye [Body Part, Organ, or Organ Component]
   827   C0026649:Movement [Organism Function]
   827   C0439834:Slow [Qualitative Concept]
   827   C1280202:Eye [Body Part, Organ, or Organ Component]
   771 E C0029144:optic [Occupation or Discipline]
   771 E C0042789:Ocular [Organism Function]
   771 E C1299003:Ocular [Spatial Concept]
   734 E C0014236:Ophthalmia [Disease or Syndrome]
   734 E C0700042:Oculus [Body Location or Region]

Phrase: "and"

Phrase: "tremor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040822:Tremor [Sign or Symptom]
  1000   C1963252:Tremor [Finding]

Phrase: "and by a lower frequency of extensor plantar responses"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   790   C0034935:Extensor plantar responses [Finding]
   784   C0237629:Frequency of Responses [Temporal Concept]
           Response Frequency
   742   C0230463:Plantar [Body Location or Region]
   742   C0376249:frequency [Quantitative Concept]
   742   C0439603:Frequency [Temporal Concept]
   742   C0441994:Lower [Spatial Concept]
   742   C0442036:Plantar [Body Location or Region]
   742   C0871261:responses [Organism Attribute]
   742   C0871396:Frequency [Quantitative Concept]
   742   C1184148:Extensor [Body Location or Region]
   742   C1515981:And [Idea or Concept]
   742   C1548802:Lower [Body Location or Region]
   742   C1561548:Frequency [Qualitative Concept]
   742   C1705502:Frequency [Quantitative Concept]
   742   C2003888:Lower [Activity]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.102: The SCA2 protein was detected in families with various geographical origins: France (n = 7), Germany (n = 3), French West Indies (n = 3), as well as in Belgium (n = 1), Algeria (n = 1) and Yugoslavia (n = 1) where this mutation had not been previously reported. 

Phrase: "The SCA2 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0531288:SCA2 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected in families"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0015576:Families [Family Group]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with various geographical origins"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
   827   C0079946:origins [Classification]
   827   C0439659:Origins [Temporal Concept]
   793 E C1550512:origin [Intellectual Product]
   755 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   755 E C0314603:Genetic [Functional Concept]
   743 E C0205313:Original [Idea or Concept]
   743 E C2347409:Original [Occupational Activity]
   734 E C0005615:Birth [Organism Function]
   734 E C0035150:Reproduction [Organism Function]
   734 E C1550722:birth [Idea or Concept]
   734 E C3245487:birth [Intellectual Product]
   721 E C0454729:Natal [Geographic Area]
   721 E C0559522:Genital [Body System]
   721 E C0598240:originality [Mental Process]
   721 E C1546649:Genital [Intellectual Product]
   721 E C1550642:Genital [Body Substance]

Phrase: ":"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "(n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "French West Indies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0043122:West Indies [Geographic Area]
   827   C1556084:French [Population Group]
   827   C1705493:West [Spatial Concept]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "as well as in Belgium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0004950:Belgium [Geographic Area]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]

Phrase: "(n = 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Algeria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002037:Algeria [Geographic Area]

Phrase: "(n = 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Yugoslavia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0043436:Yugoslavia [Geographic Area]
   928 E C0241766:YUGOSLAVIAN [Population Group]

Phrase: "(n = 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "where"

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "previously"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.103: Recombination events were detected in two patients with the marker D12S1339, confirming that this marker represents the centromeric boundary of the SCA2 candidate interval. 

Phrase: "Recombination events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "were"

Phrase: "detected in two patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205448:Two [Quantitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with the marker D12S1339,"

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "this marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the centromeric boundary of the SCA2 candidate interval."
Processing 00000000.tx.104: Marker D12S1340 is closely linked to the SCA2 locus since no recombination events were detected and linkage disequilibrium was observed at this locus. 

Phrase: "Marker D12S1340"

Phrase: "is"

Phrase: "closely"

Phrase: "linked to the SCA2 locus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0752121:SCA2 [Disease or Syndrome]
   760   C1334353:SCA-2 [Gene or Genome]
   760   C1705387:SCA-2 [Gene or Genome]
   760   C1708726:Locus [Gene or Genome]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "since"

Phrase: "no recombination events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "observed at this locus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1441672:Observed [Functional Concept]
   770   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.105: The 147 bp allele of D12S1340 segregated with the disease in eight of 15 SCA2 families tested (data not shown), as well as in a Tunisian SCA2 family (25 ,26 ), but was found in only 26 of 96 control chromosomes (P<0.05). 

Phrase: "The 147 bp allele of D12S1340"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "segregated with the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in eight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205454:Eight [Quantitative Concept]

Phrase: "of 15 SCA2 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "as well as in a Tunisian SCA2 family"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0015576:Family [Family Group]
   744   C0205170:Well [Qualitative Concept]
   744   C0752121:SCA2 [Disease or Syndrome]
   744   C1334353:SCA-2 [Gene or Genome]
   744   C1704727:Family [Conceptual Entity]
   744   C1705387:SCA-2 [Gene or Genome]
   744   C3146287:Well [Manufactured Object]

Phrase: "(25 ,"

Phrase: "26"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "was"

Phrase: "found in only 26 of 96 control chromosomes"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0008633:Chromosomes [Cell Component]
   744   C0150312:Found [Quantitative Concept]
   744   C0205171:Only [Quantitative Concept]
   744   C0243148:control [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1720467:Only [Intellectual Product]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   711 E C0243095:Find [Finding]

Phrase: "(P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.106: More SCA2 families are needed to determine whether a limited number of founder events or several different mutations are involved. 

Phrase: "More SCA2 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "a limited number of founder events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "or"

Phrase: "several different mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.107: The mAb1C2 is a sensitive tool for the detection of the SCA2 protein. 

Phrase: "The mAb1C2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "a sensitive tool for the detection of the SCA2 protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0336791:Tool [Manufactured Object]
   739   C2827396:Tool [Manufactured Object]
Processing 00000000.tx.108: Only two out of 47 patients tested did not present detectable SCA2 protein. 

Phrase: "Only two out of 47 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205448:Two [Quantitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "detectable SCA2 protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0531288:SCA2 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.109: This might be due to a smaller expansion, that would be compatible with their rather late ages at onset (46 and 63 years). 

Phrase: "This"

Phrase: "might"

Phrase: "be due to a smaller expansion,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0547044:Smaller [Qualitative Concept]
   753   C0700321:Smaller [Quantitative Concept]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]

Phrase: "that"

Phrase: "would"

Phrase: "be"

Phrase: "compatible with their rather late ages at onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332290:compatible [Idea or Concept]
   744   C1524057:Compatible [Qualitative Concept]

Phrase: "(46"

Phrase: "and"

Phrase: "63 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.110: In addition, the 150 kDa protein was detected in a still asymptomatic at risk individual who carried the disease-associated haplotype. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the 150 kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected in a still asymptomatic at risk individual"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0027361:Individual [Population Group]
   744   C0035647:Risk [Qualitative Concept]
   744   C0231221:Asymptomatic [Finding]
   744   C0237401:Individual [Human]
   744   C0442726:Detected [Finding]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "who"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "the disease-associated haplotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.111: Trottier and co-workers have reported previously that the signal intensity with the mAb1C2 increases with the size of the polyglutamine tract in huntingtin, ataxin-1 and TBP (13 ). 

Phrase: "Trottier"

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "that"

Phrase: "the signal intensity with the mAb1C2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0871362:signal intensity [Quantitative Concept]
   744   C0522510:Intensity [Qualitative Concept]
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "increases with the size of the polyglutamine tract"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   767   C1268652:increase size [Finding]
   744   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   744   C0442805:Increase [Functional Concept]
   744   C0456389:size [Spatial Concept]
   744   C1185740:Tract [Body Part, Organ, or Organ Component]
   725 E C0332509:Increased size [Finding]

Phrase: "in huntingtin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415504:HUNTINGTIN [Gene or Genome]

Phrase: "ataxin-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.112: The presence of anticipation in the 16 SCA2 families, and the tendency for the signal corresponding to the 150 kDa protein to increase as age at onset decreases, suggest an unstable mutation due to a polyglutamine-coding trinucleotide expansion. 

Phrase: "The presence of anticipation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the 16 SCA2 families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "the tendency for the signal"

Phrase: "corresponding to the 150 kDa protein to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1532717:kDa [Quantitative Concept]

Phrase: "increase as age at onset decreases,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C0206132:Onset Age [Quantitative Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0547047:decreases [Quantitative Concept]
   719 E C0392756:Decrease [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an unstable mutation due to a polyglutamine-coding trinucleotide expansion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0026882:Mutation [Genetic Function]
   739   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.113: The imperfect correlation between age at onset and the intensity of the 150 kDa band, observed in some instances, may be explained, as in other neurodegenerative disorders, by the contribution of other genetic or environmental factors (18 ,27 ,28 ). 

Phrase: "The imperfect correlation between age at onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the intensity of the 150 kDa band,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "observed in some instances,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1441672:Observed [Functional Concept]
   737   C1550608:Instance [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "explained"

Phrase: ","

Phrase: "as in other neurodegenerative disorders,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   806   C1522560:Neurodegenerative Disorders [Functional Concept]
   760   C0012634:Disorders [Disease or Syndrome]

Phrase: "by the contribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribution [Activity]

Phrase: "of other genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "or"

Phrase: "environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(18 ,"

Phrase: "27 ,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.114: In these diseases, the number of CAG repeats only accounts for ~50-70% of the variability in age at onset. 

Phrase: "In these diseases,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "the number of CAG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "repeats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205341:Repeat [Functional Concept]
  1000   C1547730:Repeat [Temporal Concept]
  1000   C1705914:Repeat [Conceptual Entity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "accounts for ~50-70% of the variability"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1551359:account [Idea or Concept]
   748   C2741673:Account # [Clinical Attribute]
   748   C2827666:Variability [Conceptual Entity]
   748   C2981730:Account [Classification]

Phrase: "in age at onset."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.115: ADCA type II, characteristically associated with progressive pigmentary macular dystrophy, has been considered to be a distinct clinical entity, that differs from other ADCAs (1 ,23 ,29 -31 ). 

Phrase: "ADCA type II,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0441730:Type II [Classification]

Phrase: "characteristically"

Phrase: "associated with progressive pigmentary macular dystrophy,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   820   C2751290:Macular Dystrophy, Progressive [Disease or Syndrome]
   790   C0242383:Macular Dystrophy [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0339508:Macular dystrophy [Congenital Abnormality]
   790   C0730292:Macular dystrophy [Disease or Syndrome]
   753   C0205329:Progressive [Functional Concept]
   753   C0332574:Macular [Spatial Concept]
   753   C0333606:Dystrophy [Pathologic Function]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "has"

Phrase: "been"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a distinct clinical entity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551338:Entity [Entity]

Phrase: "that"

Phrase: "differs from other ADCAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   737   C1418447:ADCA [Gene or Genome]

Phrase: "(1 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "23 ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "29 -31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.116: This was confirmed recently by the demonstration of linkage homogeneity at the SCA7 locus in kindreds from different geographical origins (24 ,32 ,33 ). 

Phrase: "This"

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "recently by the demonstration of linkage homogeneity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0023745:linkage [Molecular Function]
   748   C0332185:Recently [Temporal Concept]
   748   C1881065:Homogeneity [Qualitative Concept]

Phrase: "at the SCA7 locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "in kindreds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598429:kindreds [Qualitative Concept]

Phrase: "from different geographical origins"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
   827   C0079946:origins [Classification]
   827   C0439659:Origins [Temporal Concept]
   793 E C1550512:origin [Intellectual Product]
   755 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   755 E C0314603:Genetic [Functional Concept]
   743 E C0205313:Original [Idea or Concept]
   743 E C2347409:Original [Occupational Activity]
   734 E C0005615:Birth [Organism Function]
   734 E C0035150:Reproduction [Organism Function]
   734 E C1550722:birth [Idea or Concept]
   734 E C3245487:birth [Intellectual Product]
   721 E C0454729:Natal [Geographic Area]
   721 E C0559522:Genital [Body System]
   721 E C0598240:originality [Mental Process]
   721 E C1546649:Genital [Intellectual Product]
   721 E C1550642:Genital [Body Substance]

Phrase: "(24 ,"

Phrase: "32 ,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.117: The detection of a 130 kDa protein in nine families with the ADCA type II phenotype strongly supports the hypothesis of genetic homogeneity. 

Phrase: "The detection of a 130 kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in nine families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "with the ADCA type II phenotype strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031437:Phenotype [Organism Attribute]
   804   C1285572:Phenotype [Laboratory Procedure]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis of genetic homogeneity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.118: However, no abnormal protein was detected in eight patients from these families, with ages at onset ranging from 27 to 55 years, and in four other kindreds. 

Phrase: "However,"

Phrase: "no abnormal protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0311448:Abnormal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected in eight patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205454:Eight [Quantitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "from these families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with ages at onset ranging"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1514721:Range [Quantitative Concept]
   779   C2348147:Range [Quantitative Concept]
   779   C3542016:Range [Intellectual Product]
   708   C0206132:age onset [Quantitative Concept]

Phrase: "from 27"

Phrase: "to 55 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and in four"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205450:Four [Quantitative Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "other kindreds."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598429:kindreds [Qualitative Concept]
Processing 00000000.tx.119: This suggests that mAb1C2 does not detect the SCA7 protein with the same sensitivity as for SCA2. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mAb1C2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the SCA7 protein with the same sensitivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as for SCA2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]
Processing 00000000.tx.120: This is reminiscent of SCA1, where the mutated protein is only detected when there are at least 55 repeats (13 ). 

Phrase: "This"

Phrase: "is"

Phrase: "reminiscent of SCA1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0871247:reminiscence [Mental Process]

Phrase: "where"

Phrase: "the mutated protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "there"

Phrase: "are at least 55 repeats"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205341:repeats [Functional Concept]
   760   C0450382:55 [Intellectual Product]
   760   C1551058:Are [Quantitative Concept]
   760   C1705914:Repeats [Conceptual Entity]
   726 E C1547730:Repeat [Temporal Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.121: A low level of expression in some lymphoblastoid cell lines might also explain the absence of detectable protein. 

Phrase: "A"

Phrase: "low level of expression"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C3244092:expression level [Idea or Concept]
   770   C0205251:low [Qualitative Concept]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1299352:Low [Qualitative Concept]
   770   C1547707:Level [Geographic Area]
   770   C1550472:low [Idea or Concept]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "in some lymphoblastoid cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   966   C0682526:lymphoblastoid cell line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "might"

Phrase: "also"

Phrase: "explain"

Phrase: "the absence of detectable protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.122: Consistent with this hypothesis, the SCA7 protein was detected in the nuclear fraction but not in whole cell extracts of patients with onset at 20, 22 and 40 years. 

Phrase: "Consistent with this hypothesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the SCA7 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected in the nuclear fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0442726:Detected [Finding]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "but"

Phrase: "not in whole cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C0444667:Whole [Quantitative Concept]
   770   C1269647:Cell [Cell]
   770   C1518422:Not [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "extracts of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C2828366:Extract [Substance]

Phrase: "with onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "at 20,"

Phrase: "22"

Phrase: "and"

Phrase: "40 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.123: The use of nuclear extracts, therefore, increases the sensitivity of the SCA7 protein assay. 

Phrase: "The use of nuclear extracts,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "therefore,"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the sensitivity of the SCA7 protein assay."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.124: The absence of the 130 kDa protein in four ADCA type II kindreds does not rule out the homogeneity of linkage of this disease to the SCA7 locus. 

Phrase: "The absence of the 130 kDa protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "in four ADCA type II kindreds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0598429:kindreds [Qualitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the homogeneity of linkage of this disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1881065:Homogeneity [Qualitative Concept]

Phrase: "to the SCA7 locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.125: Additional proteins containing expanded polyglutamine tracts of 150 or 180 kDa were also observed in lymphoblastoid cell lines from ADCA type II patients. 

Phrase: "Additional proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "expanded polyglutamine tracts of 150"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1185740:tracts [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "180 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "observed in lymphoblastoid cell lines"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   828   C0682526:lymphoblastoid cell line [Cell]
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "from ADCA type II patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.126: They were not found in the brain, however, of one patient. 

Phrase: "They"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "found in the brain,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0150312:Found [Quantitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0243095:Find [Finding]

Phrase: "however,"

Phrase: "of one patient."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]
Processing 00000000.tx.127: The significance of these additional proteins is not clear. 

Phrase: "The significance of these additional proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.128: Dimer or trimerization (34 ), as observed with the TBP (Y. Trottier, unpublished data) or non-covalent association with other proteins cannot account for the apparent molecular weight of these proteins. 

Phrase: "Dimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimer [Chemical Viewed Structurally]

Phrase: "or"

Phrase: "trimerization"

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "observed with the TBP"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1441672:Observed [Functional Concept]

Phrase: "(Y. Trottier,"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")"

Phrase: "or"

Phrase: "non-covalent association with other proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "cannot"

Phrase: "account for the apparent molecular weight of these proteins."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0026385:Molecular Weight [Quantitative Concept]
   742   C0005910:weight [Organism Attribute]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0043100:Weight [Quantitative Concept]
   742   C0750489:apparent [Idea or Concept]
   742   C1305866:weight [Diagnostic Procedure]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1551359:account [Idea or Concept]
   742   C1705104:Weight [Idea or Concept]
   742   C2741673:Account # [Clinical Attribute]
   742   C2981730:Account [Classification]
Processing 00000000.tx.129: These additional proteins may originate, however, from somatic mosaicism of the glutamine-coding trinucleotide repeat expansion, alternative splicing, post-translational modifications or from covalent linkage to other proteins. 

Phrase: "These additional proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "originate"

Phrase: ","

Phrase: "however,"

Phrase: "from somatic mosaicism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1866227:Somatic mosaicism [Finding]
   861   C0026578:Mosaicism [Organism Attribute]
   861   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   861   C2987512:mosaicism [Organism]

Phrase: "of the glutamine-coding trinucleotide repeat expansion,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0524894:Trinucleotide Repeat Expansion [Cell or Molecular Dysfunction]
   840   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205341:Repeat [Functional Concept]
   804   C1547730:Repeat [Temporal Concept]
   804   C1705914:Repeat [Conceptual Entity]

Phrase: "alternative splicing,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002345:Alternative Splicing [Genetic Function]
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "post-translational modifications"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modifications [Molecular Function]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1704687:Post [Manufactured Object]
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]

Phrase: "or from covalent linkage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0023745:linkage [Molecular Function]
   770   C1511539:Covalent [Molecular Function]

Phrase: "to other proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.130: In HD, migration as a smear or as multiple bands of mutated, but not normal, proteins, has not yet been explained (9 ,12 ,35 ). 

Phrase: "In HD,"

Phrase: "migration as a smear"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "or as multiple bands of mutated,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0175723:Bands [Medical Device]
   753   C0439064:Multiple [Quantitative Concept]
   753   C1705285:Mutated [Cell or Molecular Dysfunction]
   719 E C0439645:Band [Spatial Concept]
   719 E C1513776:Mutate [Genetic Function]
   719 E C1521913:band [Cell Component]

Phrase: "but"

Phrase: "not normal, proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0860902:normal protein [Finding]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "explained"

Phrase: "(9 ,"

Phrase: "12 ,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.131: In a number of families, despite the analysis of patients with the earliest age at onset in 24 with ADCA type I, three with ADCA type III as well as in seven isolated cases of cerebellar ataxia, no proteins containing long polyglutamine tracts were detected. 

Phrase: "In a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "despite the analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with the earliest age at onset"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   886   C1833334:Early-onset [Finding]
   875   C0206132:age onset [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0332162:Onset [Qualitative Concept]

Phrase: "in 24"

Phrase: "with ADCA type I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "three with ADCA type III"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0441731:Type III [Classification]
   760   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   760   C0205449:Three [Quantitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0439070:III [Intellectual Product]
   760   C1418447:ADCA [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]
   760   C1705160:III [Qualitative Concept]

Phrase: "as well as in seven isolated cases of cerebellar ataxia,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   760   C0007758:Cerebellar Ataxia [Sign or Symptom]
   760   C1853237:Isolated cases [Finding]
   739   C0004134:Ataxia [Sign or Symptom]
   739   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   739   C0205170:Well [Qualitative Concept]
   739   C0205409:Isolated [Functional Concept]
   739   C0205453:Seven [Quantitative Concept]
   739   C0868928:Cases [Functional Concept]
   739   C1533148:Cases [Quantitative Concept]
   739   C1548221:Isolated [Idea or Concept]
   739   C1707522:Cerebellar [Tissue]
   739   C3146287:Well [Manufactured Object]
   706 E C1706255:CASE [Medical Device]
   706 E C1706256:Case [Conceptual Entity]

Phrase: "no proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "long polyglutamine tracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:tracts [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.132: This result does not exclude the hypothesis that glutamine-encoding trinucleotide repeat expansions are involved in some of these families, particularly in the ADCA type I kindreds in which significant anticipation was found. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that glutamine-encoding trinucleotide repeat expansions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0524894:Trinucleotide Repeat Expansions [Cell or Molecular Dysfunction]
   840   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205341:Repeat [Functional Concept]
   804   C1547730:Repeat [Temporal Concept]
   804   C1705914:Repeat [Conceptual Entity]

Phrase: "are"

Phrase: "involved in some of these families,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0015576:Families [Family Group]
   753   C1314939:Involved [Functional Concept]
   753   C1704727:Family [Conceptual Entity]

Phrase: "particularly in the ADCA type I kindreds"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0441729:Type I [Classification]
   748   C0021966:I- [Inorganic Chemical]
   748   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0332307:Type [Qualitative Concept]
   748   C0598429:kindreds [Qualitative Concept]
   748   C1418447:ADCA [Gene or Genome]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "in which significant anticipation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679106:anticipation [Mental Process]

Phrase: "was"

Phrase: "found."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]
Processing 00000000.tx.133: Low levels of expression in the lymphoblastoid cell lines, or size of the polyglutamine expansion below the detection threshold of mAb1C2, might preclude detection. 

Phrase: "Low levels of expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   802   C3244092:expression level [Idea or Concept]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the lymphoblastoid cell lines,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   966   C0682526:lymphoblastoid cell line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "or"

Phrase: "size of the polyglutamine expansion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0456389:size [Spatial Concept]

Phrase: "below the detection threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: "of mAb1C2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "might"

Phrase: "preclude"

Phrase: "detection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.134: In conclusion, mAb1C2 has proven to be a sensitive tool for identifying expanded polyglutamine tracts, particularly in patients carrying the SCA2 mutation. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "mAb1C2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "has"

Phrase: "proven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456369:Proven [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a sensitive tool for identifying expanded polyglutamine tracts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0336791:Tool [Manufactured Object]
   744   C2827396:Tool [Manufactured Object]

Phrase: "particularly in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the SCA2 mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.135: It also facilitated detailed analysis of SCA2 families, that were not informative in linkage studies, before the corresponding gene could be cloned. 

Phrase: "It also"

Phrase: "facilitated"

Phrase: "detailed analysis of SCA2 families,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "not informative in linkage studies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986490:Informative [Qualitative Concept]

Phrase: "before"

Phrase: "the corresponding gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "could"

Phrase: "be"

Phrase: "cloned."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]
Processing 00000000.tx.136: While different proteins with polyglutamine expansions were detected in lymphoblasts of ADCA type II patients, only the 130 kDa protein was detected in the cerebral cortex. 

Phrase: "While"

Phrase: "different proteins with polyglutamine expansions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected in lymphoblasts of ADCA type II patients,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   793   C0752125:ADCA, TYPE II [Disease or Syndrome]
   770   C0441730:Type II [Classification]
   750   C1550335:Patient type [Classification]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0053776:ADCA [Organic Chemical,Pharmacologic Substance]
   744   C0229613:Lymphoblasts [Cell]
   744   C0332307:Type [Qualitative Concept]
   744   C0442726:Detected [Finding]
   744   C1167770:Lymphoblasts [Laboratory Procedure]
   744   C1418447:ADCA [Gene or Genome]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the 130 kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected in the cerebral cortex."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C0442726:Detected [Finding]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C2700441:Cortex [Plant]
Processing 00000000.tx.137: The use of brain, instead of lymphoblasts, extracts is probably a more accurate and sensitive method. 

Phrase: "The use of brain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "instead of lymphoblasts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0229613:Lymphoblasts [Cell]
  1000   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "a more accurate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443131:Accurate [Qualitative Concept]

Phrase: "and"

Phrase: "sensitive method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.138: Although no new proteins with expanded polyglutamine tracts have been identified in the course of this study, mAb1C2 is a promising tool for the screening of other disorders with anticipation, such as familial Parkinson's disease (36 ) or autosomal dominant spastic paraplegia (37 -39 ). 

Phrase: "Although"

Phrase: "no new proteins with expanded polyglutamine tracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "identified in the course of this study,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205396:Identified [Qualitative Concept]
   748   C0557651:Study [Manufactured Object]
   748   C0750729:Course [Temporal Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C2603343:Study [Research Activity]

Phrase: "mAb1C2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "a promising tool for the screening of other disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0336791:Tool [Manufactured Object]
   742   C2827396:Tool [Manufactured Object]

Phrase: "with anticipation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679106:anticipation [Mental Process]

Phrase: "such as familial Parkinson's disease"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0030567:Parkinson Disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]

Phrase: "(36"

Phrase: ")"

Phrase: "or"

Phrase: "autosomal dominant spastic paraplegia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1858712:Autosomal dominant spastic paraplegia [Disease or Syndrome]
   861   C0037772:Spastic Paraplegia [Disease or Syndrome]
   812   C0030486:Paraplegia [Disease or Syndrome]
   812   C0443306:Spastic [Sign or Symptom]
   741 E C0857021:Paraplegic [Finding]

Phrase: "(37 -39"

Phrase: ")."
Processing 00000000.tx.139: MATERIALS AND METHODS Subjects Fifty seven families and seven isolated cases with cerebellar ataxia (15 ), in which the SCA1, SCA3/MJD and DRPLA mutations were excluded (16 -18 ), were analyzed in an ongoing clinical and molecular study of ADCA. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "Fifty seven families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "seven isolated cases with cerebellar ataxia"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C1853237:Isolated cases [Finding]
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "in which"

Phrase: "the SCA1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0752120:SCA1 [Disease or Syndrome]

Phrase: "SCA3/MJD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   923   C0024408:Machado-Joseph Disease [Disease or Syndrome]
           Joseph Disease
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "DRPLA mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]

Phrase: "were"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "(16 -18"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "analyzed in an ongoing clinical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205210:Clinical [Qualitative Concept]
   760   C0549178:ONGOING [Idea or Concept]
   760   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "molecular study of ADCA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1521991:Molecular [Qualitative Concept]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.140: Forty index cases fulfilled the diagnostic criteria of ADCA type I: progressive and unremitting cerebellar ataxia of autosomal dominant inheritance, and dysarthria associated with at least one other symptom (ophthalmoplegia, optic atrophy, pyramidal or extra pyramidal signs, deep sensory loss or dementia) (1 ,2 ). 

Phrase: "Forty index cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   867   C2597943:Index case [Temporal Concept]
   867   C2987736:Index Case [Population Group]
   827   C0868928:Cases [Functional Concept]
   827   C0918012:Index [Intellectual Product]
   827   C1533148:Cases [Quantitative Concept]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "fulfilled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Fulfill [Idea or Concept]

Phrase: "the diagnostic criteria of ADCA type I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0679228:diagnostic criteria [Intellectual Product]
   748   C0243161:criteria [Intellectual Product]

Phrase: ":"

Phrase: "progressive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205329:Progressive [Functional Concept]

Phrase: "and"

Phrase: "unremitting cerebellar ataxia of autosomal dominant inheritance,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0007758:Cerebellar Ataxia [Sign or Symptom]
   748   C0004134:Ataxia [Sign or Symptom]
   748   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   748   C1707522:Cerebellar [Tissue]

Phrase: "and"

Phrase: "dysarthria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013362:Dysarthria [Mental or Behavioral Dysfunction]

Phrase: "associated with"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332281:Associated with [Qualitative Concept]
           Associated
   799 E C0750490:Associate [Idea or Concept]
   799 E C1706221:Associate [Professional or Occupational Group]

Phrase: "at least one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "other symptom"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1457887:Symptom, NOS [Sign or Symptom]

Phrase: "(ophthalmoplegia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029089:Ophthalmoplegia [Sign or Symptom]

Phrase: "optic atrophy,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0029124:Optic Atrophy [Disease or Syndrome]
   861   C0015392:Optic [Body Part, Organ, or Organ Component]
   861   C0029144:optic [Occupation or Discipline]
   861   C0333641:Atrophy [Pathologic Function]
   789 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "pyramidal"

Phrase: "or"

Phrase: "extra pyramidal signs,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0234132:Pyramidal signs [Sign or Symptom]
   827   C0220912:signs [Functional Concept]
   827   C0220913:signs [Manufactured Object]
   827   C0311392:SIGNS [Finding]
   793 E C1547188:Sign [Idea or Concept]

Phrase: "deep sensory loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0278134:Sensory loss [Sign or Symptom]
   827   C1517945:Loss [Quantitative Concept]

Phrase: "or"

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "(1 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.141: Six of these families were reported to be linked (19 ,21 ,22 ) and another possibly linked (20 ), to the SCA2 locus. 

Phrase: "Six of these families"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015576:Families [Family Group]
   770   C0205452:Six [Quantitative Concept]
   770   C1704727:Family [Conceptual Entity]

Phrase: "were"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "(19 ,"

Phrase: "21 ,"

Phrase: "22"

Phrase: ")"

Phrase: "and"

Phrase: "another possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "to the SCA2 locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.142: Four families presented with a `pure' cerebellar ataxia, which was suggestive of ADCA type III. 

Phrase: "Four families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "presented with a `pure' cerebellar ataxia,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0007758:Cerebellar Ataxia [Sign or Symptom]
   753   C0004134:Ataxia [Sign or Symptom]
   753   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   753   C0449450:Presented [Idea or Concept]
   753   C1707522:Cerebellar [Tissue]
   753   C2247561:PurE [Molecular Function]
   719 E C0150312:Present [Quantitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "suggestive of ADCA type III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332299:Suggestive of [Functional Concept]
           suggestive
Processing 00000000.tx.143: In the 13 other index cases, the cerebellar ataxia segregated with progressive macular degeneration (ADCA type II) (23 ,24 ). 

Phrase: "In the 13"

Phrase: "other index cases,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   966   C2597943:Index case [Temporal Concept]
   966   C2987736:Index Case [Population Group]
   861   C0868928:Cases [Functional Concept]
   861   C0918012:Index [Intellectual Product]
   861   C1533148:Cases [Quantitative Concept]
   861   C1552854:index [Idea or Concept]
   861   C1637833:% index [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "the cerebellar ataxia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007758:Cerebellar Ataxia [Sign or Symptom]
   861   C0004134:Ataxia [Sign or Symptom]
   861   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellar [Tissue]
   789 E C0234366:Ataxic [Sign or Symptom]

Phrase: "segregated with progressive macular degeneration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0024437:Macular degeneration [Disease or Syndrome]
   806   C0242383:Macular Degeneration [Disease or Syndrome]
   760   C0011164:Degeneration [Pathologic Function]
   760   C0205329:Progressive [Functional Concept]
   760   C0332574:Macular [Spatial Concept]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "(ADCA type II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0441730:Type II [Classification]

Phrase: ")"

Phrase: "(23 ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.144: Linkage to the SCA7 locus was already demonstrated in three of these families (24 ). 

Phrase: "Linkage to the SCA7 locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023745:linkage [Molecular Function]

Phrase: "was"

Phrase: "already"

Phrase: "demonstrated in three of these families"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0015576:Families [Family Group]
   753   C0205449:Three [Quantitative Concept]
   753   C1704727:Family [Conceptual Entity]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.145: Proteins from 18 individuals without known pathology and seven with proven SCA1 or SCA3/MJD mutation were used as controls for the screening. 

Phrase: "Proteins from 18 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0054966:Protein 18 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "without known pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "seven with proven SCA1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205453:Seven [Quantitative Concept]
   770   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0456369:Proven [Qualitative Concept]
   770   C0752120:SCA1 [Disease or Syndrome]

Phrase: "or"

Phrase: "SCA3/MJD mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]
   717   C0024408:Machado-Joseph Disease [Disease or Syndrome]

Phrase: "were"

Phrase: "used as controls"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "for the screening."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0220908:Screening [Health Care Activity]
  1000   C0220909:screening [Functional Concept]
  1000   C1698960:screening [Intellectual Product]
  1000   C1710031:Screening [Diagnostic Procedure]
  1000   C1710477:SCREENING [Research Activity]
Processing 00000000.tx.146: Preparation of whole protein extracts from lymphoblastoid cell lines Lymphoblastoid cell lines were established for 187 individuals by transformation with the Epstein-Barr virus (40 ). 

Phrase: "Preparation of whole protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: "extracts from lymphoblastoid cell lines Lymphoblastoid cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0007600:Cell lines [Cell]
   767   C0007592:Cell Extracts [Cell Component]
   767   C0682526:lymphoblastoid cell line [Cell]
   744   C0007634:Cell [Cell]
   744   C0205132:lines [Spatial Concept]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2828366:Extract [Substance]
   711 E C1550648:Line [Substance]
   711 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "established for 187 individuals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0443211:Established [Qualitative Concept]
   770   C1272684:Established [Qualitative Concept]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "by transformation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040682:Transformation [Cell Function]
  1000   C1510411:Transformation [Pathologic Function]
  1000   C1705163:Transformation [Research Activity]

Phrase: "with the Epstein-Barr virus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0014644:Epstein-Barr Virus [Virus]
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
   827   C1396851:Epstein [Disease or Syndrome]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.147: Two different protocols of extraction were used. 

Phrase: "Two different protocols of extraction"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0442711:Protocols [Intellectual Product]
   726 E C1507394:Protocol [Intellectual Product]
   726 E C1522729:Protocol [Intellectual Product]
   726 E C2348563:Protocol [Intellectual Product]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.148: Cells were washed in phosphate-buffered saline (PBS) and resuspended in either (i) 50 mM Tris-HCl pH 8.0, 10% (v/v) glycerol, 5 mM EDTA, 150 mM KCl, 1 mM phenylmethylsulfonyl fluoride (PMSF), 20 [mu]M Leu-peptine and 5 [mu]g/ml A-protonine, or (ii) 50 mM Tris-HCl pH 8, 1% Triton X-100, 0.5% NP-40, 10 mM 2-mercaptoethanol, 4% (v/v) glycerol, 1 mM PMSF, 20 [mu]M Leu-peptine and 5 [mu]g/ml A-protonine. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed in phosphate-buffered saline (PBS)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "resuspended in either"

Phrase: "(i) 50 mM Tris-HCl pH 8.0,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C0020283:[pH] [Quantitative Concept]
   793   C0021966:I- [Inorganic Chemical]
   793   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   793   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   793   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]
   793   C0814229:TRI [Intellectual Product]

Phrase: "10%"

Phrase: "(v/v) glycerol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "150 mM KCl,"

Phrase: "1 mM phenylmethylsulfonyl fluoride (PMSF),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20"

Phrase: "[mu]M Leu-peptine"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[mu]g/ml A-protonine,"

Phrase: "or (ii"

Phrase: ")"

Phrase: "50 mM Tris-HCl pH 8,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0020283:[pH] [Quantitative Concept]
   799   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   799   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C0814229:TRI [Intellectual Product]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "0.5% NP-40,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0068941:NP-40 [Organic Chemical,Pharmacologic Substance]
   861   C0444499:0/5 [Quantitative Concept]
   812   C0439509:/40 [Temporal Concept]
   812   C1706141:NP [Gene or Genome]

Phrase: "10 mM 2-mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "4%"

Phrase: "(v/v) glycerol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "1 mM PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20"

Phrase: "[mu]M Leu-peptine"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[mu]g/ml A-protonine."
Processing 00000000.tx.149: Cells were left for 20 min at 4oC followed by a sonication, then centrifuged at 15 000 g for 20 min at 4oC. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "left for 20 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1552822:left [Functional Concept]

Phrase: "at 4oC"

Phrase: "followed by a sonication,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0037680:Sonication [Research Activity]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged at 15 000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4oC."
Processing 00000000.tx.150: The supernatant was collected and the protein concentration determined by the Bradford assay (Biorad). 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "the protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "determined by the Bradford assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]

Phrase: "(Biorad"

Phrase: ")."
Processing 00000000.tx.151: Aliquots were stored at -80oC until further analysis. 

Phrase: "Aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -80oC until further analysis."
Processing 00000000.tx.152: Preparation of cytosolic and nuclear extracts from lymphoblastoid cell lines According to Lee et al. 

Phrase: "Preparation of cytosolic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0455052:Preparation [Health Care Activity]
   790   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "nuclear extracts from lymphoblastoid cell lines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0007592:Cell Extracts [Cell Component]
   756   C1518434:Nuclear Extract [Biomedical or Dental Material]
   753   C0521447:Nuclear [Spatial Concept]
   719   C2828366:Extract [Substance]

Phrase: "According to Lee et al."
Processing 00000000.tx.153: (41 ), cells were washed in PBS and the pellet was resuspended in 2 vols of buffer A (1.5 mM MgCl2, 10 mM KCl, 10 mM HEPES pH 7.9, 1 mM PMSF, 0.5 mM dithiothreitol (DTT), 20 [mu]M Leu-peptine and 5 [mu]g/ml A-protonine). 

Phrase: "(41"

Phrase: ")"

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed in PBS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "the pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in 2 vols of buffer A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   714   C0449468:VOL [Quantitative Concept]
   714   C0560268:vol% [Quantitative Concept]
   714   C1690016:% vol [Qualitative Concept]

Phrase: "(1.5 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10 mM KCl,"

Phrase: "10 mM HEPES pH 7.9,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]

Phrase: "1 mM PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.5 mM dithiothreitol (DTT),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "20"

Phrase: "[mu]M Leu-peptine"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[mu]g/ml A-protonine"

Phrase: ")."
Processing 00000000.tx.154: The cells were kept at 4oC for 20 min, then passed through a needle (0.25 gauge) at least 10 times to destroy the plasma membrane. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "kept at 4oC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0333118:Keep [Functional Concept]

Phrase: "for 20 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "passed through a needle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027551:Needle [Medical Device]
   770   C1704318:Needle [Medical Device]
   770   C1882041:Needle [Spatial Concept]
   770   C2828386:Passed [Finding]

Phrase: "(0.25 gauge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0456638:25 gauge [Quantitative Concept]
   827   C0456564:Gauge [Spatial Concept]
   827   C1521879:GAGE [Immunologic Factor]

Phrase: ")"

Phrase: "at least 10 times to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0040223:times [Temporal Concept]
   812   C1632851:Times [Quantitative Concept]
   779 E C3541383:Time [Temporal Concept]
   741 E C0442043:Temporal [Spatial Concept]
   741 E C2362314:Temporal [Temporal Concept]

Phrase: "destroy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681205:Destroy [Idea or Concept]

Phrase: "the plasma membrane."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.155: After centrifugation at 13 000 g for 10 min at 4oC, the cytosolic fraction was removed and stored at -80oC. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 13 000 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4oC,"

Phrase: "the cytosolic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -80oC."
Processing 00000000.tx.156: The pellet, containing the nuclear fraction, was washed twice with buffer A and finally resuspended in 2/3 volume of buffer C (25% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 0.42 M NaCl, 20 mM HEPES pH 7.9, 1 mM PMSF, 0.5 mM DTT, 20 [mu]M Leu-peptine and 5 [mu]g/ml A-protonine). 

Phrase: "The pellet,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the nuclear fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with buffer A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "finally"

Phrase: "resuspended in 2/3 volume of buffer C (25% glycerol,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0808397:Volume 2 [Quantitative Concept]
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   739   C0449468:*Volume [Quantitative Concept]
   739   C1690016:% volume [Qualitative Concept]
   739   C1705102:Volume [Intellectual Product]
   739   C2700258:Volume [Laboratory Procedure]

Phrase: "1.5 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.2 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.42 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "20 mM HEPES pH 7.9,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]

Phrase: "1 mM PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.5 mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "20"

Phrase: "[mu]M Leu-peptine"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[mu]g/ml A-protonine"

Phrase: ")."
Processing 00000000.tx.157: After 10 min at 4oC and centrifugation at 13 000 g for 10 min at 4oC, the supernatant containing the nuclear fraction was collected and stored at -80oC. 

Phrase: "After 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4oC"

Phrase: "and"

Phrase: "centrifugation at 13 000 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4oC,"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the nuclear fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -80oC."
Processing 00000000.tx.158: Protein separation and Western blot Protein samples (50 [mu]g/lane) were separated by SDS-PAGE, either using a 4-20% acrylamide/bisacrylamide (39/1) gradient gel (Biorad) for the screening, or a 6% acrylamide/bisacrylamide (39/1) gel. 

Phrase: "Protein separation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036679:Separation [Pathologic Function]
   861   C0237868:Separation [Social Behavior]
   861   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "and"

Phrase: "Western blot Protein samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "(50"

Phrase: "[mu]g/lane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708639:Lane [Spatial Concept]
   734   C1532982:mU/g [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "separated by SDS-PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "either"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 4-20% acrylamide/bisacrylamide"

Phrase: "(39/1"

Phrase: ")"

Phrase: "gradient gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "(Biorad"

Phrase: ")"

Phrase: "for the screening,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0220908:Screening [Health Care Activity]
  1000   C0220909:screening [Functional Concept]
  1000   C1698960:screening [Intellectual Product]
  1000   C1710031:Screening [Diagnostic Procedure]
  1000   C1710477:SCREENING [Research Activity]

Phrase: "or"

Phrase: "a 6% acrylamide/bisacrylamide"

Phrase: "(39/1"

Phrase: ")"

Phrase: "gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.159: Proteins were then transferred at 4oC for 90 min onto nitrocellulose ( Hybond ECL, Amersham) which was blocked with 5% non-fat dry milk, 0.02% Tween for 1 h at room temperature. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred at 4oC"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0348011:transferred [Functional Concept]
   756 E C0040671:Transfer [Mental Process]
   756 E C1705822:Transfer [Activity]

Phrase: "for 90 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "onto nitrocellulose"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   916 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "( Hybond ECL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1332684:ECL [Gene or Genome]

Phrase: "Amersham"

Phrase: ")"

Phrase: "which"

Phrase: "was"

Phrase: "blocked with 5% non-fat dry milk,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   774   C0991850:MILK FAT [Lipid,Pharmacologic Substance]
   748   C0011682:Dry [Natural Phenomenon or Process]
   748   C0026131:Milk [Body Substance]
   748   C0028778:Blocked [Pathologic Function]
   748   C0205222:Dry [Qualitative Concept]
   748   C0332206:Blocked [Functional Concept]
   748   C0349374:Milk [Food]
   748   C0424612:FAT [Organism Attribute]
   748   C0444318:Milk [Substance]
   748   C1512080:Dry [Qualitative Concept]
   748   C1518422:Non [Functional Concept]
   748   C2825079:Milk [Food]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "0.02% Tween for 1 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0041420:tween [Organic Chemical,Pharmacologic Substance]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.160: Membranes were incubated in 3% non-fat dry milk with the mAb1C2 (1:2000) overnight at 4oC, washed three times for 10 min each in PBS, and then treated with anti-mouse antisera conjugated to horseradish peroxidase (Amersham) at 1:10 000 in 3% non-fat dry milk for 45 min at room temperature. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated in 3% non-fat dry milk"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   774   C0991850:MILK FAT [Lipid,Pharmacologic Substance]
   748   C0011682:Dry [Natural Phenomenon or Process]
   748   C0026131:Milk [Body Substance]
   748   C0205222:Dry [Qualitative Concept]
   748   C0349374:Milk [Food]
   748   C0424612:FAT [Organism Attribute]
   748   C0444318:Milk [Substance]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1512080:Dry [Qualitative Concept]
   748   C1518422:Non [Functional Concept]
   748   C2825079:Milk [Food]

Phrase: "with the mAb1C2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000"

Phrase: ")"

Phrase: "overnight at 4oC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times for 10 min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "each in PBS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1457900:Each [Quantitative Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with anti-mouse antisera"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "conjugated to horseradish peroxidase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0330510:Horseradish [Food]
   770   C0522529:Conjugated [Spatial Concept]
   770   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   770   C1110641:Horseradish [Plant]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(Amersham"

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "10 000 in 3% non-fat dry milk"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0991850:MILK FAT [Lipid,Pharmacologic Substance]
   767   C1883310:10^3 [Quantitative Concept]
   744   C0011682:Dry [Natural Phenomenon or Process]
   744   C0026131:Milk [Body Substance]
   744   C0205222:Dry [Qualitative Concept]
   744   C0349374:Milk [Food]
   744   C0424612:FAT [Organism Attribute]
   744   C0444318:Milk [Substance]
   744   C1512080:Dry [Qualitative Concept]
   744   C1518422:Non [Functional Concept]
   744   C2825079:Milk [Food]

Phrase: "for 45 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.161: After washing three times for 10 min each in PBS, filters were processed for enhanced chemiluminescence according to the recommendations of the supplier (ECL kit, Amersham) and the blots were exposed to ECL films (Amersham) for 15 s-2 h. 

Phrase: "After"

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "three times for 10 min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "each in PBS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1457900:Each [Quantitative Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "processed for enhanced chemiluminescence"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C1522240:Processed [Phenomenon or Process]
   770   C2349975:Enhanced [Activity]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "according to the recommendations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034866:recommendations [Idea or Concept]

Phrase: "of the supplier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0470689:Supplier [Health Care Related Organization]
  1000   C0470690:supplier [Health Care Related Organization]

Phrase: "(ECL kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0812225:KIT [Medical Device]
   861   C1150635:KIT [Molecular Function]
   861   C1705212:Kit [Medical Device]
   861   C1705213:KIT [Medical Device]
   861   C3273202:Kit [Manufactured Object]

Phrase: "Amersham"

Phrase: ")"

Phrase: "and"

Phrase: "the blots"

Phrase: "were"

Phrase: "exposed to ECL films"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0086296:Films [Manufactured Object]
   770   C1332684:ECL [Gene or Genome]
   737 E C1561571:film [Biomedical or Dental Material]
   737 E C1561572:film [Substance]

Phrase: "(Amersham"

Phrase: ")"

Phrase: "for 15 s-2 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.162: Due to a signal background caused by the presence of normal proteins containing polyglutamine stretches, the results of the Western blots were interpreted after comparison of the detection profiles with known SCA1, SCA2, SCA3 and SCA7 patients and healthy controls. 

Phrase: "Due to a signal background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "caused by the presence of normal proteins"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0332443:Normal presence [Qualitative Concept]
   762   C0860902:normal protein [Finding]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205307:Normal [Qualitative Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0439166:% normal [Quantitative Concept]
   748   C2347086:% Normal [Quantitative Concept]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "polyglutamine stretches,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0270814:Stretches [Disease or Syndrome]
   827 E C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "the results of the Western blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "were"

Phrase: "interpreted after comparison of the detection profiles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C1285553:interpreted [Functional Concept]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   748   C1707455:Comparison [Activity]
   714   C1979963:Profile [Laboratory Procedure]
   714   C2003903:Profile [Functional Concept]

Phrase: "with known SCA1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0752120:SCA1 [Disease or Syndrome]

Phrase: "SCA2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: "SCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024408:SCA3 [Disease or Syndrome]

Phrase: "and"

Phrase: "SCA7 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "healthy controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C2986479:Healthy Control [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.163: Linkage analysis of the SCA2 locus Two microsatellite markers (D12S1328 = D12S1339 = AFM240we1 and D12S1329 = D12S1340 = AFM291xe9), flanking the 1 cM SCA2 candidate interval were amplified by PCR and resolved in 6% acrylamide gels as previously described (22 ,26 ). 

Phrase: "Linkage analysis of the SCA2 locus Two microsatellite markers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0796345:linkage analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0023745:linkage [Molecular Function]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "(D12S1328"

Phrase: "= D12S1339"

Phrase: "= AFM240we1"

Phrase: "and"

Phrase: "D12S1329"

Phrase: "= D12S1340"

Phrase: "= AFM291xe9"

Phrase: ")"

Phrase: ","

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the 1 cM SCA2 candidate interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1272706:Interval [Temporal Concept]
   804   C1552654:Interval [Idea or Concept]
   804   C1552713:Interval [Intellectual Product]

Phrase: "were"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "resolved in 6% acrylamide gels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]
   760   C1514893:Resolved [Idea or Concept]
   760   C2699488:Resolved [Conceptual Entity]
   726 E C1382104:Gel [Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(22 ,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.164: Lod score analysis was performed using the LINKAGE package with the parameters set as in Gispert et al. 

Phrase: "Lod score analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0023956:Lod Score [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the LINKAGE package with the parameters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0013194:Package [Medical Device]
   753   C2700580:Package [Manufactured Object]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "as in Gispert et al."
Processing 00000000.tx.165: (26 ) and Lezin et al. 

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: "Lezin et al."
Processing 00000000.tx.166: (22 ). 

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.167: Statistical analysis Comparisons of means were performed with the non-parametric Mann-Whitney U test, and comparison of frequencies with the [chi]2 test. 

Phrase: "Statistical analysis Comparisons of means"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "performed with the non-parametric Mann-Whitney U test,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   818   C0242927:Mann-Whitney U Test [Quantitative Concept]
   784   C1708930:Mann-Whitney Test [Intellectual Product]
   784   C1709255:Non-Parametric Test [Intellectual Product]
   762   C1711157:Parametric Test [Intellectual Product]
   742   C0022885:Test [Laboratory Procedure]
   742   C0039593:Test [Functional Concept]
   742   C0392366:test [Intellectual Product]
   742   C0884358:Performed [Functional Concept]
   742   C1518422:Non [Functional Concept]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "comparison of frequencies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "with the [chi]2 test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
Processing 00000000.tx.168: Mean values are given with the standard deviations. 

Phrase: "Mean values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0042295:Values [Qualitative Concept]
   861   C0444504:Mean [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "given with the standard deviations."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   773   C0871420:Standard deviation [Quantitative Concept]
   760   C1442162:GIVEN [Conceptual Entity]
   760   C1442989:Standard [Qualitative Concept]
   760   C1550718:given [Idea or Concept]
   760   C2828392:Standard [Intellectual Product]
   760   C3244317:given [Intellectual Product]
   726   C0012727:Deviation [Spatial Concept]
   726   C0205419:Deviation [Qualitative Concept]
   726   C1705236:Deviation [Finding]
   726 E C1947971:Give [Functional Concept]
Processing 00000000.tx.169: ACKNOWLEDGEMENTS The authors are indebted to Drs M. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "are"

Phrase: "indebted to Drs M."
Processing 00000000.tx.170: Ruberg, S. 

Phrase: "Ruberg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.171: Vyas, S. 

Phrase: "Vyas,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.172: Faur and E. 

Phrase: "Faur"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.173: Leguern for their help and technical advice. 

Phrase: "Leguern for their"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "and"

Phrase: "technical advice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0150600:Advice [Health Care Activity]
Processing 00000000.tx.174: We especially thank Professors J. 

Phrase: "We especially"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Professors J."
Processing 00000000.tx.175: Julien, D. 

Phrase: "Julien,"

Phrase: "D."
Processing 00000000.tx.176: Laplane, G. 

Phrase: "Laplane,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.177: Rancurel, B. 

Phrase: "Rancurel,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.178: Dubois, J-C. 

Phrase: "Dubois,"

Phrase: "J-C."
Processing 00000000.tx.179: Vernant, and Drs H. 

Phrase: "Vernant,"

Phrase: "and"

Phrase: "Drs H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.180: Chneiweiss, M. 

Phrase: "Chneiweiss,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.181: Serdaru, D. 

Phrase: "Serdaru,"

Phrase: "D."
Processing 00000000.tx.182: Caparros-Lefevre, C. 

Phrase: "Caparros-Lefevre,"

Phrase: "C."
Processing 00000000.tx.183: Vial, D. 

Phrase: "Vial,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184301:Phial [Medical Device]
  1000   C1533199:Vial [Quantitative Concept]
  1000   C1706497:VIAL [Medical Device]

Phrase: "D."
Processing 00000000.tx.184: Smadja and A. 

Phrase: "Smadja"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.185: Lezin for referring some of the probands. 

Phrase: "Lezin for referring"

Phrase: "some of the probands."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C0702111:probands [Organism Attribute]
   770   C3540770:Some [Intellectual Product]
   737 E C1948021:Proband [Family Group]
Processing 00000000.tx.186: The contribution of J. 

Phrase: "The contribution of J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]
Processing 00000000.tx.187: Bou, A. 

Phrase: "Bou,"

Phrase: "A."
Processing 00000000.tx.188: Camuzat, C. 

Phrase: "Camuzat,"

Phrase: "C."
Processing 00000000.tx.189: Ponthieux and C. 

Phrase: "Ponthieux"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.190: Penet, who prepared the cell lines of the patients, is greatly appreciated. 

Phrase: "Penet,"

Phrase: "who"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "the cell lines of the patients,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0007600:Cell lines [Cell]
   790   C0007634:THE CELL [Cell]
           Cell
   753   C0205132:lines [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "is"

Phrase: "greatly"

Phrase: "appreciated."
Processing 00000000.tx.191: We also thank Drs E. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs E."
Processing 00000000.tx.192: Hirsch and P. 

Phrase: "Hirsch"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.193: Damier for providing us with brain cortex from one ADCA type II patient. 

Phrase: "Damier for providing"

Phrase: "us with brain cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]

Phrase: "from one ADCA type II patient."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:*^patient [Patient or Disabled Group]
Processing 00000000.tx.194: This work was supported financially by the Association Franaise contre les Myopathies (AFM), the VERUM foundation, the Groupement de Recherches et d'Etudes sur les Gnomes (GREG) and the Association pour la Recherche sur les Maladies Gntiques Neurologiques et Psychiatriques (ADRMGNP). 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "financially by the Association Franaise contre les Myopathies (AFM),"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0004083:Association [Mental Process]
   744   C0026848:Myopathies [Disease or Syndrome]
   744   C0227192:LES [Body Part, Organ, or Organ Component]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]
   744   C1414864:Les [Gene or Genome]

Phrase: "the VERUM foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "the Groupement de Recherches"

Phrase: "et"

Phrase: "d'"

Phrase: "Etudes sur les Gnomes"

Phrase: "(GREG"

Phrase: ")"

Phrase: "and"

Phrase: "the Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "pour"

Phrase: "la Recherche sur les Maladies Gntiques Neurologiques et Psychiatriques"

Phrase: "(ADRMGNP"

Phrase: ")."
Processing 00000000.tx.195: Y.T. and N.A. are held by a fellowship from the Hereditary Disease Foundation and AFM, respectively. 

Phrase: "Y.T."

Phrase: "and"

Phrase: "N.A."

Phrase: "are"

Phrase: "held by a fellowship"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0015770:Fellowship [Educational Activity]
   770   C1948036:held [Idea or Concept]
   770   C2987518:hELD [Amino Acid, Peptide, or Protein]
   737 E C1553387:Hold [Idea or Concept]
   737 E C1948035:Hold [Activity]

Phrase: "from the Hereditary Disease Foundation"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   734   C0019247:Hereditary Disease [Disease or Syndrome]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "AFM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0026848:Myopathies [Disease or Syndrome]

Phrase: "respectively."
Processing 00000000.tx.196: REFERENCES 1 Harding, A.E. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Harding,"

Phrase: "A.E."
Processing 00000000.tx.197: (1993) Clinical features and classification of inherited ataxias. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Clinical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "classification of inherited ataxias."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classification [Classification]
   770   C0008903:classification [Functional Concept]
   770   C0678229:classification [Occupational Activity]
Processing 00000000.tx.198: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.199: Neurol., 61, 1-14. 

Phrase: "Neurol.,"

Phrase: "61,"

Phrase: "1-14."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.200: MEDLINE Abstract 2 Durr, A., Chneiweiss, H., Khati, C., Stevanin, G., Cancel, G., Feingold, J., Agid, Y. and Brice, A. 

Phrase: "MEDLINE Abstract 2 Durr,"

Phrase: "A.,"

Phrase: "Chneiweiss,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Khati,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Feingold,"

Phrase: "J.,"

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.201: (1993) Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Phenotypic variability in autosomal dominant cerebellar ataxia type I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1853719:Phenotypic variability [Finding]
   742   C2827666:Variability [Conceptual Entity]

Phrase: "is"

Phrase: "unrelated to genetic heterogeneity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0445356:Unrelated [Finding]
   770   C1704623:Unrelated [Qualitative Concept]
Processing 00000000.tx.202: Brain, 116, 1497-1508. 

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "116,"

Phrase: "1497-1508."
Processing 00000000.tx.203: MEDLINE Abstract 3 Durr, A. and Brice, A. 

Phrase: "MEDLINE Abstract 3 Durr,"

Phrase: "A."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.204: (1996) Genetics of movement disorders. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Genetics of movement disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017398:Genetics [Biomedical Occupation or Discipline]
   770   C0017399:genetics [Biologic Function]
Processing 00000000.tx.205: Curr. 

Phrase: "Curr."
Processing 00000000.tx.206: Opin. 

Phrase: "Opin."
Processing 00000000.tx.207: Neurol., 9, 290-297. 

Phrase: "Neurol.,"

Phrase: "9,"

Phrase: "290-297."
Processing 00000000.tx.208: MEDLINE Abstract 4 Rosenberg, R.N. 

Phrase: "MEDLINE Abstract 4 Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1979969:Rosenberg [Spatial Concept]

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.209: (1995) Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Autosomal dominant cerebellar phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0031437:Phenotypes [Organism Attribute]
   779 E C1285572:Phenotype [Laboratory Procedure]

Phrase: ":"

Phrase: "the genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "has"

Phrase: "settled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1266099:SETTLE [Neoplastic Process]

Phrase: "the issue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.210: Neurology, 45, 1-5. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "45,"

Phrase: "1-5."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.211: MEDLINE Abstract 5 Ashley, C.T.J. and Warren, S.T. 

Phrase: "MEDLINE Abstract 5 Ashley,"

Phrase: "C.T.J."

Phrase: "and"

Phrase: "Warren,"

Phrase: "S."

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.212: (1995) Trinucleotide repeat expansion and human disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Trinucleotide repeat expansion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0524894:Trinucleotide Repeat Expansion [Cell or Molecular Dysfunction]
   901   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "human disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.213: Annu. 

Phrase: "Annu."
Processing 00000000.tx.214: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.215: Genet., 29, 703-728. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "29,"

Phrase: "703-728."
Processing 00000000.tx.216: 6 DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.P., Carraway, R., Reeves, S.A., Boyce, F.M. and Aronin, N. 

Phrase: "6 DiFiglia,"

Phrase: "M."

Phrase: ","

Phrase: "Sapp,"

Phrase: "E.,"

Phrase: "Chase,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Schwarz,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Meloni,"

Phrase: "A.,"

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Martin,"

Phrase: "E.,"

Phrase: "Vonsattel,"

Phrase: "J.P.,"

Phrase: "Carraway,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Reeves,"

Phrase: "S."

Phrase: "A.,"

Phrase: "Boyce,"

Phrase: "F.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2348507:F/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Aronin,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.217: (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Huntingtin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415504:HUNTINGTIN [Gene or Genome]

Phrase: "is"

Phrase: "a cytoplasmic protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with vesicles"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0333262:VESICLES [Acquired Abnormality]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1622418:vesicle [Cell Component]
   756 E C1706221:Associate [Professional or Occupational Group]
   706 E C0205378:Vesicular [Qualitative Concept]

Phrase: "in human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rat brain neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
   734   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.218: Neuron, 14, 1075-1081. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "14,"

Phrase: "1075-1081."
Processing 00000000.tx.219: MEDLINE Abstract 7 Ide, K., Nukina, N., Masuda, N., Goto, J. and Kanazawa, I. 

Phrase: "MEDLINE Abstract 7 Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0328104:Ide [Fish]
   812   C1415875:IDE [Gene or Genome]
   812   C2826366:IDE [Idea or Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nukina,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Masuda,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Goto,"

Phrase: "J."

Phrase: "and"

Phrase: "Kanazawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.220: (1995) Abnormal gene product identified in Huntington's disease lymphocytes and brain. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Abnormal gene product"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "identified in Huntington's disease lymphocytes"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0020179:Huntington Disease [Disease or Syndrome]
   806   C2919056:Huntington's Disease [Functional Concept]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0024264:Lymphocytes [Cell]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.221: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.222: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.223: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.224: Commun., 209, 1119-1125. 

Phrase: "Commun.,"

Phrase: "209,"

Phrase: "1119-1125."
Processing 00000000.tx.225: MEDLINE Abstract 8 Jou, Y.S. and Myers, R.M. 

Phrase: "MEDLINE Abstract 8 Jou,"

Phrase: "Y.S."

Phrase: "and"

Phrase: "Myers,"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.226: (1995) Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Evidence from antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "the CAG repeat in the Huntington disease gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205341:Repeat [Functional Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]

Phrase: "is"

Phrase: "expressed in the protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.227: Hum. 

Phrase: "Hum."
Processing 00000000.tx.228: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.229: Genet., 4, 465-469. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "465-469."
Processing 00000000.tx.230: MEDLINE Abstract 9 Schilling, G., Sharp, A.H., Loev, S.J., Wagster, M.V., Li, S.H., Stine, O.C. and Ross, C.A. 

Phrase: "MEDLINE Abstract 9 Schilling,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sharp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1444775:Sharp [Finding]
  1000   C1539835:SHARP [Gene or Genome]

Phrase: "A.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Loev,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Wagster,"

Phrase: "M."

Phrase: "V., Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Stine,"

Phrase: "O.C."

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C.A."
Processing 00000000.tx.231: (1995) Expression of the Huntington's disease (IT15) protein product in HD patients. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Expression of the Huntington's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(IT15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415504:IT15 [Gene or Genome]
  1000   C2982389:IT15 [Gene or Genome]

Phrase: ")"

Phrase: "protein product in HD patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.232: Hum. 

Phrase: "Hum."
Processing 00000000.tx.233: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.234: Genet., 4, 1365-1371. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "1365-1371."
Processing 00000000.tx.235: MEDLINE Abstract 10 Servadio, A., Koshy, B., Armstrong, D., Antalffy, B., Orr, H.T. and Zoghbi, H.Y. 

Phrase: "MEDLINE Abstract 10 Servadio,"

Phrase: "A.,"

Phrase: "Koshy,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Armstrong,"

Phrase: "D."

Phrase: ","

Phrase: "Antalffy,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Orr,"

Phrase: "H.T."

Phrase: "and"

Phrase: "Zoghbi,"

Phrase: "H.Y."
Processing 00000000.tx.236: (1995) Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Expression analysis of the ataxin-1 protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1882495:Protein Expression Analysis [Laboratory Procedure]
   774   C1514534:Protein Analysis [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "from normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "spinocerebellar ataxia type 1 individuals."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   771   C0027361:Individual [Population Group]
   771   C0237401:Individual [Human]
   771   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
Processing 00000000.tx.237: Nature Genet., 10, 94-98. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "94-98."
Processing 00000000.tx.238: MEDLINE Abstract 11 Sharp, A.H., Loev, S.J., Schilling, G., Li, S.H., Li, X.J., Bao, J., Wagster, M.V., Kotzuk, J.A., Steiner, J.P., Lo, A., Hedreen, J., Sisodia, S., Snyder, S.H., Dawson, T.M., Ryugo, D.K. and Ross, C.A. 

Phrase: "MEDLINE Abstract 11 Sharp, A.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0033727:H+ [Element, Ion, or Isotope]
   799   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0441932:H+ [Classification]
   799   C0564385:/h [Quantitative Concept]

Phrase: "Loev,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Schilling,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X.J.,"

Phrase: "Bao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0428597:BAO [Finding]

Phrase: "J.,"

Phrase: "Wagster,"

Phrase: "M."

Phrase: "V., Kotzuk,"

Phrase: "J.A.,"

Phrase: "Steiner,"

Phrase: "J.P.,"

Phrase: "Lo,"

Phrase: "A.,"

Phrase: "Hedreen,"

Phrase: "J.,"

Phrase: "Sisodia,"

Phrase: "S."

Phrase: ","

Phrase: "Snyder,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Ryugo,"

Phrase: "D."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C.A."
Processing 00000000.tx.239: (1995) Widespread expression of Huntington's disease gene (IT15) protein product. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Widespread expression of Huntington's disease gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(IT15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415504:IT15 [Gene or Genome]
  1000   C2982389:IT15 [Gene or Genome]

Phrase: ")"

Phrase: "protein product."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.240: Neuron, 14, 1065-1074. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "14,"

Phrase: "1065-1074."
Processing 00000000.tx.241: MEDLINE Abstract 12 Trottier, Y., Devys, D., Imbert, G., Saudou, F., An, I., Lutz, Y., Weber, C., Agid, Y., Hirsch, E.C. and Mandel, J.L. 

Phrase: "MEDLINE Abstract 12 Trottier,"

Phrase: "Y.,"

Phrase: "Devys,"

Phrase: "D."

Phrase: ","

Phrase: "Imbert,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Saudou,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "An,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lutz,"

Phrase: "Y.,"

Phrase: "Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Hirsch,"

Phrase: "E.C."

Phrase: "and"

Phrase: "Mandel,"

Phrase: "J.L."
Processing 00000000.tx.242: (1995) Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cellular localization of the Huntington's disease protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C2612729:cellular protein localisation [Cell Function]
   778   C1660642:cellular localisation [Cell Function]
   774   C0597704:protein localisation [Cell Function]
   774   C1159772:Protein Localization [Cell Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "discrimination of the normal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012632:Discrimination [Mental Process]
   770   C2987623:Discrimination [Social Behavior]

Phrase: "and"

Phrase: "mutated form."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]
Processing 00000000.tx.243: Nature Genet., 10, 104-110. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "104-110."
Processing 00000000.tx.244: MEDLINE Abstract 13 Trottier, Y., Lutz, Y., Stevanin, G., Imbert, G., Devys, D., Cancel, G., Saudou, F., Weber, C., David, G., Laszlo, T., Agid, Y., Brice, A. and Mandel, J.L. 

Phrase: "MEDLINE Abstract 13 Trottier,"

Phrase: "Y.,"

Phrase: "Lutz,"

Phrase: "Y.,"

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Imbert,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Devys,"

Phrase: "D."

Phrase: ","

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Saudou,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "David,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Laszlo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Brice,"

Phrase: "A."

Phrase: "and"

Phrase: "Mandel,"

Phrase: "J.L."
Processing 00000000.tx.245: (1995) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Polyglutamine expansion as a pathological epitope"

Phrase: "in Huntington's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "four dominant cerebellar ataxias."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0007758:Cerebellar Ataxias [Sign or Symptom]
   812   C0004134:Ataxias [Sign or Symptom]
   729 E C0234366:Ataxic [Sign or Symptom]
Processing 00000000.tx.246: Nature, 378, 403-406. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "378,"

Phrase: "403-406."
Processing 00000000.tx.247: MEDLINE Abstract 14 Yazawa, I., Nukina, N., Hashida, H., Goto, J., Yamada, M. and Kanazawa, I. 

Phrase: "MEDLINE Abstract 14 Yazawa,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Nukina,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hashida,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Goto,"

Phrase: "J.,"

Phrase: "Yamada,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Kanazawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.248: (1995) Abnormal gene product identified in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) brain. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Abnormal gene product"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "identified in hereditary dentatorubral-pallidoluysian atrophy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   790   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   753   C0205396:Identified [Qualitative Concept]
   753   C0333641:Atrophy [Pathologic Function]
   753   C0439660:Hereditary [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "(DRPLA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   861   C0333641:Atrophy [Pathologic Function]
   789 E C0151514:Atrophic [Disease or Syndrome]

Phrase: ")"

Phrase: "brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.249: Nature Genet., 10, 99-103. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "99-103."
Processing 00000000.tx.250: MEDLINE Abstract 15 Klockgether, T., Schroth, G., Diener, H.C. and Dichgans, J. 

Phrase: "MEDLINE Abstract 15 Klockgether,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schroth,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Diener,"

Phrase: "H.C."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Dichgans,"

Phrase: "J."
Processing 00000000.tx.251: (1990) Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Idiopathic cerebellar ataxia of late onset"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0393524:Cerebellar Ataxia, Late Onset [Disease or Syndrome]
   790   C0007758:Cerebellar Ataxia [Sign or Symptom]
   753   C0004134:Ataxia [Sign or Symptom]
   753   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   753   C1707522:Cerebellar [Tissue]

Phrase: ":"

Phrase: "natural history"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0175860:Natural History [Occupation or Discipline]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0205296:Natural [Functional Concept]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "and"

Phrase: "MRI morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.252: J. 

Phrase: "J."
Processing 00000000.tx.253: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.254: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.255: Psychiatr., 53, 297-305. 

Phrase: "Psychiatr.,"

Phrase: "53,"

Phrase: "297-305."
Processing 00000000.tx.256: 16 Dubourg, O., Durr, A., Cancel, G., Stevanin, G., Chneiweiss, H., Penet, C., Agid, Y. and Brice, A. 

Phrase: "16 Dubourg,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chneiweiss,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Penet,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.257: (1995) Analysis of the SCA1 CAG repeat in a large number of families with dominant ataxia: clinical and molecular correlations. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Analysis of the SCA1 CAG repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in a large number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with dominant ataxia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004134:Ataxia [Sign or Symptom]
   789 E C0234366:Ataxic [Sign or Symptom]

Phrase: ":"

Phrase: "clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "molecular correlations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.258: Ann. 

Phrase: "Ann."
Processing 00000000.tx.259: Neurol., 37, 176-180. 

Phrase: "Neurol.,"

Phrase: "37,"

Phrase: "176-180."
Processing 00000000.tx.260: MEDLINE Abstract 17 Dubourg, O., Durr, A., Chneiweiss, H., Stevanin, G., Cancel, G., Penet, C., Agid, Y. and Brice, A. 

Phrase: "MEDLINE Abstract 17 Dubourg,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Chneiweiss,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Penet,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.261: (1995) La forme ataxo-choreique de DRPLA existe-t-elle en Europe ? Recherche de la mutation dans 120 familles. 

Phrase: "(1995"

Phrase: ")"

Phrase: "La forme ataxo-choreique de DRPLA existe-t-elle en Europe ? Recherche de la mutation dans 120 familles."
Processing 00000000.tx.262: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.263: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.264: (Paris), 151, 657-660. 

Phrase: "(Paris"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "151,"

Phrase: "657-660."
Processing 00000000.tx.265: MEDLINE Abstract 18 Durr, A., Stevanin, G., Cancel, G., Duyckaerts, C., Abbas, N., Didierjean, O., Chneiweiss, H., Benomar, A., Lyon-Caen, O., Julien, J., Serdaru, M., Penet, C., Agid, Y. and Brice, A. 

Phrase: "MEDLINE Abstract 18 Durr,"

Phrase: "A.,"

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Duyckaerts,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Abbas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Didierjean,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Chneiweiss,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Benomar,"

Phrase: "A.,"

Phrase: "Lyon-Caen,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Julien,"

Phrase: "J.,"

Phrase: "Serdaru,"

Phrase: "M."

Phrase: ","

Phrase: "Penet,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.266: (1996) Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular and neuropathological features. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Spinocerebellar ataxia 3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0024408:Spinocerebellar Ataxia-3 [Disease or Syndrome]
   901   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   827   C0004134:Ataxia [Sign or Symptom]
   755 E C0234366:Ataxic [Sign or Symptom]

Phrase: "and"

Phrase: "Machado-Joseph disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024408:Machado-Joseph Disease [Disease or Syndrome]
           Joseph Disease
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "clinical, molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "neuropathological features."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.267: Ann. 

Phrase: "Ann."
Processing 00000000.tx.268: Neurol., 39, 490-499. 

Phrase: "Neurol.,"

Phrase: "39,"

Phrase: "490-499."
Processing 00000000.tx.269: MEDLINE Abstract 19 Burk, K., Abele, M., Fetter, M., Dichgans, J., Skalej, M., Laccone, F., Didierjean, O., Brice, A. and Klockgether, T. 

Phrase: "MEDLINE Abstract 19 Burk,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Abele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522459:abele [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Fetter,"

Phrase: "M."

Phrase: ","

Phrase: "Dichgans,"

Phrase: "J.,"

Phrase: "Skalej,"

Phrase: "M."

Phrase: ","

Phrase: "Laccone,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Didierjean,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Brice,"

Phrase: "A."

Phrase: "and"

Phrase: "Klockgether,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.270: (1996) Autosomal dominant cerebellar ataxia type I: clinical features and magnetic resonance imaging in families with SCA1, SCA2 and SCA3. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Autosomal dominant cerebellar ataxia type I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   885   C0441735:Dominant type I [Intellectual Product]
   827   C0441729:Type I [Classification]
   799   C0021966:I- [Inorganic Chemical]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "clinical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "magnetic resonance imaging in families"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   862   C0024485:Magnetic Resonance Imaging [Diagnostic Procedure]
   862   C1552358:Magnetic Resonance Imaging [Professional or Occupational Group]
   806   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   806   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   806   C1551403:Magnetic resonance [Laboratory Procedure]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0024488:Magnetic [Occupation or Discipline]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0231881:Resonance [Finding]
   760   C0459800:resonance [Natural Phenomenon or Process]
   760   C0563532:magnetic [Natural Phenomenon or Process]
   760   C0684213:Resonance [Qualitative Concept]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "with SCA1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0752120:SCA1 [Disease or Syndrome]

Phrase: "SCA2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: "and"

Phrase: "SCA3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024408:SCA3 [Disease or Syndrome]
Processing 00000000.tx.271: Brain, in press. 

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in press."
Processing 00000000.tx.272: MEDLINE Abstract 20 Cancel, G., Stevanin, G., Durr, A., Chneiweiss, H., Penet, C., Pothin, Y., Agid, Y. and Brice, A. 

Phrase: "MEDLINE Abstract 20"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Chneiweiss,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Penet,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pothin,"

Phrase: "Y.,"

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.273: (1995) SCA2 is not a major locus for ADCA type I in French families. 

Phrase: "(1995"

Phrase: ")"

Phrase: "SCA2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a major locus for ADCA type I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1708726:Locus [Gene or Genome]

Phrase: "in French families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.274: Am. 

Phrase: "Am."
Processing 00000000.tx.275: J. 

Phrase: "J."
Processing 00000000.tx.276: Med. 

Phrase: "Med."
Processing 00000000.tx.277: Genet., 60, 382-385. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "60,"

Phrase: "382-385."
Processing 00000000.tx.278: MEDLINE Abstract 21 Durr, A., Smadja, D., Cancel, G., Lezin, A., Stevanin, G., Mikol, J., Bellance, R., Buisson, G.G., Chneiweiss, H., Dellanave, J., Agid, Y., Brice, A. and Vernant, J.C. 

Phrase: "MEDLINE Abstract 21 Durr,"

Phrase: "A.,"

Phrase: "Smadja,"

Phrase: "D."

Phrase: ","

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lezin,"

Phrase: "A.,"

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mikol,"

Phrase: "J.,"

Phrase: "Bellance,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Buisson,"

Phrase: "G.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1319635:g/g [Quantitative Concept]

Phrase: "Chneiweiss,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dellanave,"

Phrase: "J.,"

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Brice,"

Phrase: "A."

Phrase: "and"

Phrase: "Vernant,"

Phrase: "J.C."
Processing 00000000.tx.279: (1995) Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Autosomal dominant cerebellar ataxia type I in Martinique"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0441735:Dominant type I [Intellectual Product]
   770   C0441729:Type I [Classification]
   744   C0021966:I- [Inorganic Chemical]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(French West Indies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0043122:West Indies [Geographic Area]
   827   C1556084:French [Population Group]
   827   C1705493:West [Spatial Concept]

Phrase: ")"

Phrase: ":"

Phrase: "clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "neuropathological analysis of 53 patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "from three unrelated SCA2 families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.280: Brain, 118, 1573-1581. 

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "118,"

Phrase: "1573-1581."
Processing 00000000.tx.281: MEDLINE Abstract 22 Lezin, A., Cancel, G., Stevanin, G., Smadja, D., Vernant, J.C., Durr, A., Martial, J., Buisson, G.G., Bellance, R., Chneiweiss, H., Agid, Y. and Brice, A. 

Phrase: "MEDLINE Abstract 22 Lezin,"

Phrase: "A.,"

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Smadja,"

Phrase: "D."

Phrase: ","

Phrase: "Vernant,"

Phrase: "J.C., Durr,"

Phrase: "A.,"

Phrase: "Martial,"

Phrase: "J.,"

Phrase: "Buisson,"

Phrase: "G.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1319635:g/g [Quantitative Concept]

Phrase: "Bellance,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Chneiweiss,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.282: (1996) Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): genetic analysis of three unrelated SCA2 families. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Autosomal dominant cerebellar ataxia type I in Martinique"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0441735:Dominant type I [Intellectual Product]
   770   C0441729:Type I [Classification]
   744   C0021966:I- [Inorganic Chemical]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(French West Indies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0043122:West Indies [Geographic Area]
   827   C1556084:French [Population Group]
   827   C1705493:West [Spatial Concept]

Phrase: ")"

Phrase: ":"

Phrase: "genetic analysis of three unrelated SCA2 families."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0679560:genetic analysis [Laboratory Procedure]
   778   C0796344:Genetic Analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.283: Hum. 

Phrase: "Hum."
Processing 00000000.tx.284: Genet., 97, 671-676. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "671-676."
Processing 00000000.tx.285: MEDLINE Abstract 23 Benomar, A., Le Guern, E., Durr, A., Ouhabi, H., Stevanin, G., Yahyaoui, M., Chkili, T., Agid, Y. and Brice, A. 

Phrase: "MEDLINE Abstract 23 Benomar,"

Phrase: "A.,"

Phrase: "Le Guern,"

Phrase: "E.,"

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Ouhabi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yahyaoui,"

Phrase: "M."

Phrase: ","

Phrase: "Chkili,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.286: (1994) Autosomal-dominant cerebellar ataxia with retinal degeneration (ADCA type II) is genetically different from ADCA type I. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Autosomal-dominant cerebellar ataxia with retinal degeneration"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0007758:Cerebellar Ataxia [Sign or Symptom]
   778   C0443147:Autosomal dominant [Intellectual Product]
   774   C0262404:Cerebellar degeneration [Disease or Syndrome]
   748   C0004134:Ataxia [Sign or Symptom]
   748   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   748   C0596142:autosomal [Cell Component]
   748   C1527180:Dominant [Functional Concept]
   748   C1707522:Cerebellar [Tissue]

Phrase: "(ADCA type II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0441730:Type II [Classification]

Phrase: ")"

Phrase: "is"

Phrase: "genetically different from ADCA type I."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.287: Ann. 

Phrase: "Ann."
Processing 00000000.tx.288: Neurol., 35, 439-444. 

Phrase: "Neurol.,"

Phrase: "35,"

Phrase: "439-444."
Processing 00000000.tx.289: MEDLINE Abstract 24 Benomar, A., Krols, L., Stevanin, G., Cancel, G., Le Guern, E., David, G., Ouhabi, H., Martin, J.J., Durr, A., Zaim, A., Ravise, N., Busque, C., Penet, C., Van Regemorter, N., Weissenbach, J., Yahyaoui, M., Chkili, T., Agid, Y., Van Broeckhoven, C. and Brice, A. 

Phrase: "MEDLINE Abstract 24 Benomar,"

Phrase: "A.,"

Phrase: "Krols,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Le Guern,"

Phrase: "E.,"

Phrase: "David,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ouhabi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Martin,"

Phrase: "J.J.,"

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Zaim,"

Phrase: "A.,"

Phrase: "Ravise,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Busque,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Penet,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Van Regemorter,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Weissenbach,"

Phrase: "J.,"

Phrase: "Yahyaoui,"

Phrase: "M."

Phrase: ","

Phrase: "Chkili,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Van Broeckhoven,"

Phrase: "C."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.290: (1995) The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12-p21.1. 

Phrase: "(1995"

Phrase: ")"

Phrase: "The gene for autosomal dominant cerebellar ataxia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0017342:Dominant gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]

Phrase: "with pigmentary macular dystrophy"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0242383:Macular Dystrophy [Disease or Syndrome]
   901   C0339508:Macular dystrophy [Congenital Abnormality]
   901   C0730292:Macular dystrophy [Disease or Syndrome]
   827   C0333606:Dystrophy [Pathologic Function]
   755 E C0333607:Dystrophic [Functional Concept]

Phrase: "maps to chromosome 3p12-p21.1."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0008651:Chromosome 1 [Cell Component]
   783   C0814036:chromosome map [Intellectual Product]
   783   C1424473:MAP-1 [Gene or Genome]
   753   C0008633:Chromosome [Cell Component]
   753   C0024779:Map [Manufactured Object]
   753   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.291: Nature Genet., 10, 84-88. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "84-88."
Processing 00000000.tx.292: MEDLINE Abstract 25 Belal, S., Cancel, G., Stevanin, G., Hentati, F., Khati, C., Ben Hamida, C., Auburger, G., Agid, Y., Ben Hamida, M. and Brice, A. 

Phrase: "MEDLINE Abstract 25 Belal,"

Phrase: "S."

Phrase: ","

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hentati,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Khati,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ben Hamida,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Auburger,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Ben Hamida,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.293: (1994) Clinical and genetic analysis of a Tunisian family with autosomal dominant cerebellar ataxia type 1 linked to the SCA2 locus. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "genetic analysis of a Tunisian family"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0679560:genetic analysis [Laboratory Procedure]
   790   C0796344:Genetic Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "with autosomal dominant cerebellar ataxia type 1"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   827   C0007758:Cerebellar Ataxia [Sign or Symptom]
   827   C0441729:Type 1 [Classification]
   827   C0443147:Autosomal dominant [Intellectual Product]
   799   C0004134:Ataxia [Sign or Symptom]
   799   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   799   C0332307:Type [Qualitative Concept]
   799   C0596142:autosomal [Cell Component]
   799   C1527180:Dominant [Functional Concept]
   799   C1547052:*Type [Quantitative Concept]
   799   C1707522:Cerebellar [Tissue]
   727 E C0234366:Ataxic [Sign or Symptom]

Phrase: "linked to the SCA2 locus."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0752121:SCA2 [Disease or Syndrome]
   760   C1334353:SCA-2 [Gene or Genome]
   760   C1705387:SCA-2 [Gene or Genome]
   760   C1708726:Locus [Gene or Genome]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.294: Neurology, 44, 1423-1426. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "44,"

Phrase: "1423-1426."
Processing 00000000.tx.295: MEDLINE Abstract 26 Gispert, S., Lunkes, A., Santos, N., Orozco, G., Ha-Hao, D., Ratzlaff, T., Aguiar, J., Torrens, I., Heredero, L., Brice, A., Cancel, G., Stevanin, G., Vernant, J.C., Durr, A., Lepage-Lezin, A., Belal, S., Ben-Hamida, C., Pulst, S., Rouleau, G., Weissenbach, J., LePaslier, D., Kucherlapati, R., Montgomery, K., Fukui, K. and Auburger, G. 

Phrase: "MEDLINE Abstract 26 Gispert,"

Phrase: "S."

Phrase: ","

Phrase: "Lunkes,"

Phrase: "A.,"

Phrase: "Santos,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Orozco,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ha-Hao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1324275:HAO [Molecular Function]

Phrase: "D."

Phrase: ","

Phrase: "Ratzlaff,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Aguiar,"

Phrase: "J.,"

Phrase: "Torrens,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Heredero,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Brice,"

Phrase: "A.,"

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vernant,"

Phrase: "J.C., Durr,"

Phrase: "A.,"

Phrase: "Lepage-Lezin,"

Phrase: "A.,"

Phrase: "Belal,"

Phrase: "S."

Phrase: ","

Phrase: "Ben-Hamida,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pulst,"

Phrase: "S."

Phrase: ","

Phrase: "Rouleau,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Weissenbach,"

Phrase: "J.,"

Phrase: "LePaslier,"

Phrase: "D."

Phrase: ","

Phrase: "Kucherlapati,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Montgomery,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fukui,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Auburger,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.296: (1995) Localization of the candidate gene D-amino acid oxidase outside the refined 1-cM region of spinocerebellar ataxia 2. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Localization of the candidate gene D-amino acid oxidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0008630:Gene Localization [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the refined 1-cM region of spinocerebellar ataxia 2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
Processing 00000000.tx.297: Am. 

Phrase: "Am."
Processing 00000000.tx.298: J. 

Phrase: "J."
Processing 00000000.tx.299: Hum. 

Phrase: "Hum."
Processing 00000000.tx.300: Genet., 57, 972-975. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "57,"

Phrase: "972-975."
Processing 00000000.tx.301: MEDLINE Abstract 27 Gusella, J.F. and MacDonald, M.E. 

Phrase: "MEDLINE Abstract 27 Gusella,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "MacDonald,"

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.302: (1995) Huntington's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Huntington's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.303: Semin. 

Phrase: "Semin."
Processing 00000000.tx.304: Cell Biol., 6, 21-28. 

Phrase: "Cell Biol.,"

Phrase: "6,"

Phrase: "21-28."
Processing 00000000.tx.305: MEDLINE Abstract 28 Zoghbi, H.Y. and Orr, H.T. 

Phrase: "MEDLINE Abstract 28 Zoghbi,"

Phrase: "H.Y."

Phrase: "and"

Phrase: "Orr,"

Phrase: "H.T."
Processing 00000000.tx.306: (1995) Spinocerebellar ataxia type 1. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Spinocerebellar ataxia type 1."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441729:Type 1 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]
Processing 00000000.tx.307: Semin. 

Phrase: "Semin."
Processing 00000000.tx.308: Cell Biol., 6, 29-35. 

Phrase: "Cell Biol.,"

Phrase: "6,"

Phrase: "29-35."
Processing 00000000.tx.309: MEDLINE Abstract 29 Enevoldson, T.P., Sanders, M.D. and Harding, A.E. 

Phrase: "MEDLINE Abstract 29 Enevoldson,"

Phrase: "T.P.,"

Phrase: "Sanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Harding,"

Phrase: "A.E."
Processing 00000000.tx.310: (1994) Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0007758:Cerebellar Ataxia [Sign or Symptom]
   770   C0443147:Autosomal dominant [Intellectual Product]
   744   C0004134:Ataxia [Sign or Symptom]
   744   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   744   C0596142:autosomal [Cell Component]
   744   C1527180:Dominant [Functional Concept]
   744   C1707522:Cerebellar [Tissue]
Processing 00000000.tx.311: A clinical and genetic study of eight families. 

Phrase: "A"

Phrase: "clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "genetic study of eight families."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2827447:Genetic Study [Research Activity]
   797   C0199236:Family study, NOS [Diagnostic Procedure]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.312: Brain, 117, 445-460. 

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "117,"

Phrase: "445-460."
Processing 00000000.tx.313: MEDLINE Abstract 30 Gouw, L.G., Digre, K.B., Harris, C.P., Haines, J.H. and Ptacek, L.J. 

Phrase: "MEDLINE Abstract 30 Gouw,"

Phrase: "L.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439294:l g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Digre,"

Phrase: "K.B.,"

Phrase: "Harris,"

Phrase: "C.P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Haines,"

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Ptacek,"

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.314: (1994) Autosomal dominant cerebellar ataxia with retinal degeneration: clinical, neuropathologic, and genetic analysis of a large kindred. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Autosomal dominant cerebellar ataxia with retinal degeneration"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0007758:Cerebellar Ataxia [Sign or Symptom]
   778   C0443147:Autosomal dominant [Intellectual Product]
   774   C0262404:Cerebellar degeneration [Disease or Syndrome]
   748   C0004134:Ataxia [Sign or Symptom]
   748   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   748   C0596142:autosomal [Cell Component]
   748   C1527180:Dominant [Functional Concept]
   748   C1707522:Cerebellar [Tissue]

Phrase: ":"

Phrase: "clinical, neuropathologic,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   789   C1540677:neuropathology [Pathologic Function]
   789   C1555824:Neuropathology [Intellectual Product]

Phrase: "and"

Phrase: "genetic analysis of a large kindred."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0679560:genetic analysis [Laboratory Procedure]
   790   C0796344:Genetic Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.315: Neurology, 44, 1441-1447. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "44,"

Phrase: "1441-1447."
Processing 00000000.tx.316: MEDLINE Abstract 31 Martin, J.J., Van, R., N, Krols, L., Brucher, J.M., de, B., T, Szliwowski, H., Evrard, P., Ceuterick, C., Tassignon, M.J., Smet-Dieleman, H., Hayez-Delatte, F., Willems, P.J. and Van Broeckhoven, C. 

Phrase: "MEDLINE Abstract 31 Martin,"

Phrase: "J.J.,"

Phrase: "Van,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0557775:Van [Manufactured Object]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Krols,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Brucher,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "de,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011198:DE [Geographic Area]
  1000   C0017480:DE [Geographic Area]
  1000   C3541240:DE [Idea or Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Szliwowski,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Evrard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ceuterick,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Tassignon,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Smet-Dieleman,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hayez-Delatte,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Willems,"

Phrase: "P.J."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.317: (1994) On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family. 

Phrase: "(1994"

Phrase: ")"

Phrase: "On an autosomal dominant form"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]
   734   C0443147:Autosomal dominant [Intellectual Product]

Phrase: "of retinal-cerebellar degeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0035304:Retinal Degeneration [Disease or Syndrome]
   901   C0262404:Cerebellar degeneration [Disease or Syndrome]
   827   C0011164:Degeneration [Pathologic Function]
   827   C1880269:Degeneration [Functional Concept]

Phrase: ":"

Phrase: "an autopsy study of five patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "in one family."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.318: Acta Neuropathol. 

Phrase: "Acta Neuropathol."
Processing 00000000.tx.319: (Berl), 88, 277-286. 

Phrase: "(Berl"

Phrase: ")"

Phrase: ","

Phrase: "88,"

Phrase: "277-286."
Processing 00000000.tx.320: MEDLINE Abstract 32 Gouw, L.G., Kaplan, C.D., Haines, J.H., Digre, K.B., Rutledge, S.L., Matilla, A., Leppert, M., Zoghbi, H.Y. and Ptacek, L.J. 

Phrase: "MEDLINE Abstract 32 Gouw,"

Phrase: "L.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439294:l g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kaplan,"

Phrase: "C.D.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012358:c d [Therapeutic or Preventive Procedure]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Haines,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Digre,"

Phrase: "K.B.,"

Phrase: "Rutledge,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Matilla,"

Phrase: "A.,"

Phrase: "Leppert,"

Phrase: "M."

Phrase: ","

Phrase: "Zoghbi,"

Phrase: "H.Y."

Phrase: "and"

Phrase: "Ptacek,"

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.321: (1995) Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Retinal degeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035304:Retinal Degeneration [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C0035298:Retinal [Body Part, Organ, or Organ Component]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "characterizes"

Phrase: "a spinocerebellar ataxia mapping to chromosome 3p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0008630:Chromosome Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   748   C1283195:Mapping [Activity]
Processing 00000000.tx.322: Nature Genet., 10, 89-93. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "89-93."
Processing 00000000.tx.323: MEDLINE Abstract 33 Holmberg, M., Johansson, J., Forsgren, L., Heijbel, J., Sandgren, O. and Holmgren, G. 

Phrase: "MEDLINE Abstract 33 Holmberg,"

Phrase: "M."

Phrase: ","

Phrase: "Johansson,"

Phrase: "J.,"

Phrase: "Forsgren,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Heijbel,"

Phrase: "J.,"

Phrase: "Sandgren,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Holmgren,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.324: (1995) Localization of autosomal dominant cerebellar ataxia associated with retinal degeneration and anticipation to chromosome 3p12-p21.1. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Localization of autosomal dominant cerebellar ataxia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "associated with retinal degeneration"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0035304:Retinal Degeneration [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0011164:Degeneration [Pathologic Function]
   770   C0035298:Retinal [Body Part, Organ, or Organ Component]
   770   C1880269:Degeneration [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "anticipation to chromosome 3p12-p21.1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679106:anticipation [Mental Process]
Processing 00000000.tx.325: Hum. 

Phrase: "Hum."
Processing 00000000.tx.326: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.327: Genet., 4, 1441-1445. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "1441-1445."
Processing 00000000.tx.328: MEDLINE Abstract 34 Perutz, M.F., Johnson, T., Suzuki, M. and Finch, J.T. 

Phrase: "MEDLINE Abstract 34 Perutz,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Johnson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "J.T."
Processing 00000000.tx.329: (1994) Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Glutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "repeats as polar zippers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205341:Repeat [Functional Concept]
   770   C0453984:zippers [Manufactured Object]
   770   C0813983:polar [Quantitative Concept]
   770   C1547730:Repeat [Temporal Concept]
   770   C1705914:Repeat [Conceptual Entity]

Phrase: ":"

Phrase: "their possible role in inherited neurodegenerative diseases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.330: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.331: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.332: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.333: USA, 91, 5355-5358. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "91,"

Phrase: "5355-5358."
Processing 00000000.tx.334: MEDLINE Abstract 35 Aronin, N., Chase, K., Young, C., Sapp, E., Schwarz, C., Matta, N., Kornreich, R., Landwehrmeyer, B., Bird, E., Beal, M.F., Vonsattel, J.P., Smith, T., Carraway, R., Boyce, F.M., Young, A.B., Penney, J.B. and DiFiglia, M. 

Phrase: "MEDLINE Abstract 35 Aronin,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Chase,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sapp,"

Phrase: "E.,"

Phrase: "Schwarz,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Matta,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kornreich,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Landwehrmeyer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "E.,"

Phrase: "Beal,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Vonsattel,"

Phrase: "J.P.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Carraway,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Boyce,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "A.B.,"

Phrase: "Penney,"

Phrase: "J.B."

Phrase: "and"

Phrase: "DiFiglia,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.335: (1995) CAG expansion affects the expression of mutant Huntingtin in the Huntington's disease brain. 

Phrase: "(1995"

Phrase: ")"

Phrase: "CAG expansion"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the expression of mutant Huntingtin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the Huntington's disease brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0020179:Huntington Disease [Disease or Syndrome]
   734   C2919056:Huntington's Disease [Functional Concept]
Processing 00000000.tx.336: Neuron, 15, 1193-1201. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "15,"

Phrase: "1193-1201."
Processing 00000000.tx.337: MEDLINE Abstract 36 Payami, H., Bernard, S., Larsen, K., Kaye, J. and Nutt, J. 

Phrase: "MEDLINE Abstract 36 Payami,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bernard,"

Phrase: "S."

Phrase: ","

Phrase: "Larsen,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kaye,"

Phrase: "J."

Phrase: "and"

Phrase: "Nutt,"

Phrase: "J."
Processing 00000000.tx.338: (1995) Genetic anticipation in Parkinson's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Genetic anticipation in Parkinson's disease."
Meta Candidates (Total=14; Excluded=9; Pruned=0; Remaining=5)
   806   C0600498:Anticipation, Genetic [Organism Attribute]
   797   C0019247:Genetic disease [Disease or Syndrome]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   760   C0679106:anticipation [Mental Process]
   756 E C2316203:Genetic diseases [Finding]
   756 E C2924406:Genetic diseases [Laboratory Procedure]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]
Processing 00000000.tx.339: Neurology, 45, 135-138. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "45,"

Phrase: "135-138."
Processing 00000000.tx.340: MEDLINE Abstract 37 Durr, A., Brice, A., Serdaru, M., Rancurel, G., Derouesne, C., Lyon-Caen, O., Agid, Y. and Fontaine, B. 

Phrase: "MEDLINE Abstract 37 Durr,"

Phrase: "A.,"

Phrase: "Brice,"

Phrase: "A.,"

Phrase: "Serdaru,"

Phrase: "M."

Phrase: ","

Phrase: "Rancurel,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Derouesne,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lyon-Caen,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Fontaine,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.341: (1994) The phenotype of `pure' autosomal dominant spastic paraplegia. 

Phrase: "(1994"

Phrase: ")"

Phrase: "The phenotype of `pure' autosomal dominant spastic paraplegia."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   877   C1858712:Autosomal dominant spastic paraplegia [Disease or Syndrome]
   868   C2677898:Spastic paraplegia, pure [Finding]
   818   C0037772:Spastic Paraplegia [Disease or Syndrome]
   795   C0030486:Paraplegia [Disease or Syndrome]
   795   C0443306:Spastic [Sign or Symptom]
   724 E C0857021:Paraplegic [Finding]
Processing 00000000.tx.342: Neurology, 44, 1274-1277. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "44,"

Phrase: "1274-1277."
Processing 00000000.tx.343: MEDLINE Abstract 38 Gispert, S., Santos, N., Damen, R., Voit, T., Schulz, J., Klockgether, T., Orozco, G., Kreuz, F., Weissenbach, J. and Auburger, G. 

Phrase: "MEDLINE Abstract 38 Gispert,"

Phrase: "S."

Phrase: ","

Phrase: "Santos,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Damen,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Voit,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schulz,"

Phrase: "J.,"

Phrase: "Klockgether,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Orozco,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kreuz,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Weissenbach,"

Phrase: "J."

Phrase: "and"

Phrase: "Auburger,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.344: (1995) Autosomal dominant familial spastic paraplegia: reduction of the FSP1 candidate region on chromosome 14q to 7 cM and locus heterogeneity. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Autosomal dominant familial spastic paraplegia"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   924   C1858712:Autosomal dominant spastic paraplegia [Disease or Syndrome]
   840   C0037772:Spastic Paraplegia [Disease or Syndrome]
   840   C0443147:Autosomal dominant [Intellectual Product]
   804   C0015576:familial [Family Group]
   804   C0030486:Paraplegia [Disease or Syndrome]
   804   C0241888:Familial [Functional Concept]
   804   C0443306:Spastic [Sign or Symptom]
   804   C0596142:autosomal [Cell Component]
   804   C1527180:Dominant [Functional Concept]
   733 E C0857021:Paraplegic [Finding]
   733 E C1704727:Family [Conceptual Entity]

Phrase: ":"

Phrase: "reduction of the FSP1 candidate region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "on chromosome 14q"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327813:chromosome 14q [Nucleotide Sequence]
           14q

Phrase: "to 7 cM"

Phrase: "and"

Phrase: "locus heterogeneity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2986542:Locus Heterogeneity [Qualitative Concept]
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]
Processing 00000000.tx.345: Am. 

Phrase: "Am."
Processing 00000000.tx.346: J. 

Phrase: "J."
Processing 00000000.tx.347: Hum. 

Phrase: "Hum."
Processing 00000000.tx.348: Genet., 56, 183-187. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "56,"

Phrase: "183-187."
Processing 00000000.tx.349: MEDLINE Abstract 39 Hazan, J., Lamy, C., Melki, J., Munnich, A., de Recondo, J. and Weissenbach, J. 

Phrase: "MEDLINE Abstract 39 Hazan,"

Phrase: "J.,"

Phrase: "Lamy,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Melki,"

Phrase: "J.,"

Phrase: "Munnich,"

Phrase: "A.,"

Phrase: "de Recondo,"

Phrase: "J."

Phrase: "and"

Phrase: "Weissenbach,"

Phrase: "J."
Processing 00000000.tx.350: (1993) Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Autosomal dominant familial spastic paraplegia"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   924   C1858712:Autosomal dominant spastic paraplegia [Disease or Syndrome]
   840   C0037772:Spastic Paraplegia [Disease or Syndrome]
   840   C0443147:Autosomal dominant [Intellectual Product]
   804   C0015576:familial [Family Group]
   804   C0030486:Paraplegia [Disease or Syndrome]
   804   C0241888:Familial [Functional Concept]
   804   C0443306:Spastic [Sign or Symptom]
   804   C0596142:autosomal [Cell Component]
   804   C1527180:Dominant [Functional Concept]
   733 E C0857021:Paraplegic [Finding]
   733 E C1704727:Family [Conceptual Entity]

Phrase: "is"

Phrase: "genetically heterogeneous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneous [Qualitative Concept]

Phrase: "and"

Phrase: "one locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "maps to chromosome 14q."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1327813:chromosome 14q [Nucleotide Sequence]
           14q
   819   C0814036:chromosome map [Intellectual Product]
   770   C0008633:Chromosome [Cell Component]
   770   C0024779:Map [Manufactured Object]
   770   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.351: Nature Genet., 5, 163-167. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "163-167."
Processing 00000000.tx.352: MEDLINE Abstract 40 Neitzel, H. 

Phrase: "MEDLINE Abstract 40 Neitzel,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.353: (1986) A routine method for the establishment of permanent growing lymphoblastoid cell lines. 

Phrase: "(1986"

Phrase: ")"

Phrase: "A routine method for the establishment of permanent growing lymphoblastoid cell lines."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0025663:Method [Intellectual Product]
   736   C0449851:Method [Functional Concept]
   736   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.354: Hum. 

Phrase: "Hum."
Processing 00000000.tx.355: Genet., 73, 320-326. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "73,"

Phrase: "320-326."
Processing 00000000.tx.356: MEDLINE Abstract 41 Lee, K.A., Bindereif, A. and Green, M.R. 

Phrase: "MEDLINE Abstract 41 Lee,"

Phrase: "K.A.,"

Phrase: "Bindereif,"

Phrase: "A."

Phrase: "and"

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.357: (1988) A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. 

Phrase: "(1988"

Phrase: ")"

Phrase: "A small-scale procedure for preparation of nuclear extracts"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   781   C0548441:Preparation for procedure [Health Care Activity]
           preparation procedure
   742   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   742   C1948041:Procedure [Therapeutic or Preventive Procedure]
   742   C2700391:Procedure [Activity]
   742   C3274430:PROCEDURE [Health Care Activity]
   742   C3538935:Procedure [Idea or Concept]
   742   C3539779:Procedure [Intellectual Product]

Phrase: "that"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "efficient transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "pre-mRNA splicing."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1622990:pre-mRNA splicing [Genetic Function]
   901   C0086934:mRNA splicing [Genetic Function]
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]
   734   C0026661:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0035695:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.358: Gene Anal. 

Phrase: "Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.359: Technol., 5, 22-31. 

Phrase: "Technol.,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "22-31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]
Processing 00000000.tx.360: *To whom correspondence should be addressed +Present address: Gnthon, Evry, France This page is maintained by OUP admin. 

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "+Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Gnthon,"

Phrase: "Evry,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "This page"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "is"

Phrase: "maintained by OUP admin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]
Processing 00000000.tx.361: Last updated Sun Jan 12 13:36:46 GMT 1997. 

Phrase: "Last updated Sun Jan 12 13"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0038817:Sun [Natural Phenomenon or Process]
   799   C0376223:Sun [Geographic Area]
   799   C1517741:Last [Qualitative Concept]
   766   C1519814:Update [Temporal Concept]

Phrase: ":"

Phrase: "36"

Phrase: ":"

Phrase: "46 GMT 1997."
Processing 00000000.tx.362: Part of the OUP Journals World Wide Web service.

Phrase: "Part of the OUP Journals World Wide Web service."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1292711:Part of [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.363: Copyright Oxford University Press, 1996

Phrase: "Copyright Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "1996"

